<?xml version="1.0" encoding="UTF-8"?>
<drug type="small molecule" created="2015-12-03" updated="2020-01-02">
  <drugbank-id primary="true">DB11219</drugbank-id>
  <name>Enzacamene</name>
  <description>Commonly known as 4-methylbenzylidene-camphor (4-MBC), enzacamene is a camphor derivative and an organic chemical UV-B filter. It is used in cosmetic products such as sunscreen to provide skin protection against UV rays. While its effects on the human reproductive system as an endocrine disruptor are being investigated, its use in over-the-counter and cosmetic products is approved by Health Canada. Its tradenames include Eusolex 6300 (Merck) and Parsol 5000 (DSM).</description>
  <cas-number>36861-47-9</cas-number>
  <unii>8I3XWY40L9</unii>
  <average-mass>254.373</average-mass>
  <monoisotopic-mass>254.167065328</monoisotopic-mass>
  <state>solid</state>
  <groups>
    <group>approved</group>
  </groups>
  <general-references>
    <articles>
      <article>
        <ref-id>A19212</ref-id>
        <pubmed-id>23320122</pubmed-id>
        <citation>Latha MS, Martis J, Shobha V, Sham Shinde R, Bangera S, Krishnankutty B, Bellary S, Varughese S, Rao P, Naveen Kumar BR: Sunscreening agents: a review. J Clin Aesthet Dermatol. 2013 Jan;6(1):16-26.</citation>
      </article>
      <article>
        <ref-id>A32921</ref-id>
        <pubmed-id>19885997</pubmed-id>
        <citation>Carou ME, Szwarcfarb B, Deguiz ML, Reynoso R, Carbone S, Moguilevsky JA, Scacchi P, Ponzo OJ: Impact of 4-methylbenzylidene-camphor (4-MBC) during embryonic and fetal development in the neuroendocrine regulation of testicular axis in prepubertal and peripubertal male rats. Exp Clin Endocrinol Diabetes. 2009 Oct;117(9):449-54.</citation>
      </article>
      <article>
        <ref-id>A32922</ref-id>
        <pubmed-id>18221342</pubmed-id>
        <citation>Janjua NR, Kongshoj B, Andersson AM, Wulf HC: Sunscreens in human plasma and urine after repeated whole-body topical application. J Eur Acad Dermatol Venereol. 2008 Apr;22(4):456-61. doi: 10.1111/j.1468-3083.2007.02492.x. Epub 2008 Jan 23.</citation>
      </article>
      <article>
        <ref-id>A32923</ref-id>
        <pubmed-id>15589235</pubmed-id>
        <citation>Klann A, Levy G, Lutz I, Muller C, Kloas W, Hildebrandt JP: Estrogen-like effects of ultraviolet screen 3-(4-methylbenzylidene)-camphor (Eusolex 6300) on cell proliferation and gene induction in mammalian and amphibian cells. Environ Res. 2005 Mar;97(3):274-81. doi: 10.1016/j.envres.2004.07.004.</citation>
      </article>
      <article>
        <ref-id>A32924</ref-id>
        <pubmed-id>26888529</pubmed-id>
        <citation>Li VW, Tsui MP, Chen X, Hui MN, Jin L, Lam RH, Yu RM, Murphy MB, Cheng J, Lam PK, Cheng SH: Effects of 4-methylbenzylidene camphor (4-MBC) on neuronal and muscular development in zebrafish (Danio rerio) embryos. Environ Sci Pollut Res Int. 2016 May;23(9):8275-85. doi: 10.1007/s11356-016-6180-9. Epub 2016 Feb 18.</citation>
      </article>
      <article>
        <ref-id>A32925</ref-id>
        <pubmed-id>16806338</pubmed-id>
        <citation>Volkel W, Colnot T, Schauer UM, Broschard TH, Dekant W: Toxicokinetics and biotransformation of 3-(4-methylbenzylidene)camphor in rats after oral administration. Toxicol Appl Pharmacol. 2006 Oct 15;216(2):331-8. doi: 10.1016/j.taap.2006.05.012. Epub 2006 May 23.</citation>
      </article>
    </articles>
    <textbooks/>
    <links/>
    <attachments>
      <attachment>
        <ref-id>F39</ref-id>
        <title>OPINION ON 4-Methylbenzylidene camphor (4-MBC) - European Union</title>
        <url>//s3-us-west-2.amazonaws.com/drugbank/cite_this/attachments/files/000/000/039/original/sccp_o_075.pdf?1525453589</url>
      </attachment>
    </attachments>
  </general-references>
  <synthesis-reference/>
  <indication>Indicated for use as an active sunscreen agent. </indication>
  <pharmacodynamics>Several studies suggest that enzacamene elicit estrogen-like effects. In prepubertal male rats exposed to enzacamene during embryonic and fetal development, decrease in testicular weight with decreased levels of LH, GnRH, and glutamate were observed; in comparison, there was an increase in LH, GnRH, and aspartate levels in peripubertal rats [A32921]. These findings suggest that high concentrations of enzacamene during embryonic and fetal stage inhibits the testicular axis in male rats during the prepubertal stage and stimulates it during peripubertad stage [A32921]. In a study of zebrafish (Danio rerio) embryo, exposure to enzacamene during early vertebrate development was associated with muscular and neuronal defects that may result in developmental defects, including a reduction in AChE activity, disorganized pattern of slow muscle fibers, and axon pathfinding errors during motor neuron innervation [A32924]. Enzacamene displays a weak binding activity in receptors binding assays using the mammalian estrogen receptor (ER) [A32923]. </pharmacodynamics>
  <mechanism-of-action>Enzacamene absorbs UV-B rays. It is proposed that enzacamene exerts estrogen-like activities in the same direction as endogenous estrogens via nonclassical estrogen signaling mechanisms that do not involve gene regulation by the nuclear ER [A32923]. It binds to cytosolic estradiol binding sites of estrogen receptors with low to moderate affinity compared to that of the endogenous agonist. Based on the findings of a study with _Xenopus_ hepatocytes in culture, enzacamene has a potential to induce the ER gene only at higher concentrations (10–100 μmol/L). While enzacamene was not shown to activate estrogen-dependent gene transcription when tested in an ER reporter gene assay in yeast cells, it was demonstrated in _Xenopus_ hepatocytes cultures that activate ER-dependent signaling mechanisms leading to altered gene expression [A32923]. In micromolar concentrations, enzacamene accelerates cell proliferation rate in MCF-7 human breast cancer cells [A32923]. </mechanism-of-action>
  <toxicity>Oral LD50 and dermal LD50 in rat are reported to be 10,000 mg/kg [F39]. Oral TDLO in rat is 7 mg/kg [MSDS]. Oral and subcutaneous TDLO following continuous administration in rat are 476 mg/kg/4D and 4 mg/kg/2D, respectively [MSDS]. Cases of overdose have not been reported for enzacamene. Enzacamene is reported to be an endocrine disruptor that alters the reproductive axis. </toxicity>
  <metabolism>Based on the findings of a rat pharmacokinetic study, it is proposed that absorbed enzacamene following oral administration undergo extensive first-pass hepatic metabolism [A32925]. Following oral administration of enzacamene (4-MBC) in rats, detected metabolites in the plasma and urine were 3-(4-carboxybenzylidene)camphor and as four isomers of 3-(4-carboxybenzylidene)hydroxycamphor containing the hydroxyl group located in the camphor ring system with 3-(4-carboxybenzylidene)-6-hydroxycamphor as the major metabolite. However the blood concentrations of 3-(4-carboxybenzylidene)-6-hydroxycamphor were below the limit of detection following peak concentration [A32925]. &#13;
&#13;
Via hydroxylation mediated by cytochrome P450 system, 3-(4-hydroxymethylbenzylidene)camphor is formed. This metabolite is further oxidized to 3-(4-carboxybenzylidene)camphor via oxidation of alcohol dehydrogenase and aldehyde dehydrogenase, and may be further hydroxylated to form 3-(4-carboxybenzylidene)-6-hydroxycamphor mediated by CYP450 system [A32925]. </metabolism>
  <absorption>The maximum plasma concentration of enzacamene was 16ng/mL in healthy female volunteers following daily whole-body topical application of 2mg/cm^2 of sunscreen formulation at 10% (weight/weight) for four days [A19212]. Blood concentration of enzacamene (4-MBC) and its main metabolite, 3-(4-carboxybenzylidene)camphor, peaked within 10 h after oral administration of enzacamene [A32925]. </absorption>
  <half-life>The half life of enzacamene (4-MBC) and its main metabolite, 3-(4-carboxybenzylidene)camphor, displayed half-lives of approximately 15 h after reaching peak plasma concentrations after oral administration in rats [A32925].</half-life>
  <protein-binding>No pharmacokinetic data available. </protein-binding>
  <route-of-elimination>The urine concentration of 4 ng/mL and 4 ng/mL of enzacamene were observed in female and male volunteers, respectively [A32922]. In a rat pharmacokinetic study, most of orally administered enzacamene was recovered in in feces as 3-(4-carboxybenzylidene)camphor and, to a smaller extent, as 3-(4-carboxybenzylidene)-6-hydroxycamphor [A32925]. Glucuronides of both metabolites were also detectable in faces [A32925]. In urine, one isomer of 3-(4-carboxybenzylidene)hydroxycamphor was the predominant metabolite [3-(4-carboxybenzylidene)-6-hydroxycamphor], the other isomers and 3-(4-carboxybenzylidene)camphor were only minor metabolites excreted with urine [A32925]. Enterohepatic circulation of glucuronides derived from the two major 4-MBC metabolites may explain the slow excretion of 4-MBC metabolites with urine and the small percentage of the administered doses recovered in urine [A32925].</route-of-elimination>
  <volume-of-distribution>No pharmacokinetic data available. </volume-of-distribution>
  <clearance>No pharmacokinetic data available. </clearance>
  <salts/>
  <synonyms>
    <synonym language="english" coder="">(+/-)-3-(p-methylbenzylidene)camphor</synonym>
    <synonym language="english" coder="">3-(4-methylbenzylidene)camphor</synonym>
    <synonym language="english" coder="">3-(p-Methylbenzylidene)-DL-camphor</synonym>
    <synonym language="english" coder="">4-MBC</synonym>
    <synonym language="english" coder="">4-methylbenzylidene camphor</synonym>
    <synonym language="french" coder="">enzacamène</synonym>
    <synonym language="english" coder="inn/usan">Enzacamene</synonym>
    <synonym language="english" coder="">Enzacamene D-L form</synonym>
    <synonym language="spanish" coder="">enzacameno</synonym>
    <synonym language="latin" coder="">enzacamenum</synonym>
    <synonym language="english" coder="">Methyl benzylidene camphor</synonym>
  </synonyms>
  <products>
    <product>
      <name>Anthelios L - Ecran Intolerances Solaires SPF 60</name>
      <labeller>Laboratoires La Roche Posay Canada</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02237467</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1999-03-01</started-marketing-on>
      <ended-marketing-on>2009-06-05</ended-marketing-on>
      <dosage-form>Cream</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Anthelios L-lait Ecran Intol.solaire SPF 60</name>
      <labeller>Cosmair Canada Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02220423</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1996-12-31</started-marketing-on>
      <ended-marketing-on>2001-07-27</ended-marketing-on>
      <dosage-form>Lotion</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Anthelios S - Ecran Solaire SPF 30</name>
      <labeller>Laboratoires La Roche Posay Canada</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02230672</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1997-05-29</started-marketing-on>
      <ended-marketing-on>2010-06-08</ended-marketing-on>
      <dosage-form>Cream</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Anthelios-creme Solaire SPF 10</name>
      <labeller>Cosmair Canada Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02220474</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1996-12-31</started-marketing-on>
      <ended-marketing-on>1998-08-12</ended-marketing-on>
      <dosage-form>Cream</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Anthelios-ecran Invisible SPF 20</name>
      <labeller>Cosmair Canada Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02220490</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1996-12-31</started-marketing-on>
      <ended-marketing-on>1998-08-12</ended-marketing-on>
      <dosage-form>Cream</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Anthelios-lait Ecran Invisible SPF 20</name>
      <labeller>Cosmair Canada Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02220482</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1996-12-31</started-marketing-on>
      <ended-marketing-on>1998-08-12</ended-marketing-on>
      <dosage-form>Lotion</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Anthelios-stick Ecran SPF 30</name>
      <labeller>Cosmair Canada Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02220466</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1996-06-27</started-marketing-on>
      <ended-marketing-on>1999-03-16</ended-marketing-on>
      <dosage-form>Stick</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Antherpos-ceralip Solaire SPF 50</name>
      <labeller>Laboratoires La Roche Posay Canada</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02220458</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1996-12-31</started-marketing-on>
      <ended-marketing-on>2008-07-23</ended-marketing-on>
      <dosage-form>Cream</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Autobronzant Creme Fps 15</name>
      <labeller>Ombrelle Canada</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02243574</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2001-03-31</started-marketing-on>
      <ended-marketing-on>2005-07-22</ended-marketing-on>
      <dosage-form>Cream</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Autobronzant SPF 7</name>
      <labeller>Vichy Canada</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02239377</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1999-04-20</started-marketing-on>
      <ended-marketing-on>2002-08-01</ended-marketing-on>
      <dosage-form>Gel</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Bain De Soleil Protection Lotion SPF 15</name>
      <labeller>Canderm G.P.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02229532</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1998-06-04</started-marketing-on>
      <ended-marketing-on>1999-07-15</ended-marketing-on>
      <dosage-form>Lotion</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Biokids SPF 35</name>
      <labeller>Biotherm Canada</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02233072</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1998-03-16</started-marketing-on>
      <ended-marketing-on>2001-07-27</ended-marketing-on>
      <dosage-form>Lotion</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Biotherm - Lait Ecran Total SPF 25</name>
      <labeller>Biotherm Canada</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02173093</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1996-12-31</started-marketing-on>
      <ended-marketing-on>2001-07-27</ended-marketing-on>
      <dosage-form>Lotion</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>But First Water</name>
      <labeller>CNT Dream Co.,Ltd</labeller>
      <ndc-id/>
      <ndc-product-code>71909-6567</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2019-04-02</started-marketing-on>
      <ended-marketing-on>2020-04-01</ended-marketing-on>
      <dosage-form>Cream</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number>part352</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Conju Princess UV Sun Block</name>
      <labeller>Conju Inc</labeller>
      <ndc-id/>
      <ndc-product-code>59915-4001</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2010-12-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Cream</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Conju Princess UV Sun Block</name>
      <labeller>Conju Inc</labeller>
      <ndc-id/>
      <ndc-product-code>59915-2001</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2010-12-18</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Cream</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Correway Sunscreen (Waterproof)</name>
      <labeller>Ningbo Correway Cosmetics Co., Ltd.</labeller>
      <ndc-id/>
      <ndc-product-code>50600-003</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2010-04-23</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Cream</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number>part352</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Creme Auto-bronzante Bronze Dore SPF 15</name>
      <labeller>Laboratoires Clarins</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02238610</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1998-08-27</started-marketing-on>
      <ended-marketing-on>1999-03-29</ended-marketing-on>
      <dosage-form>Emulsion</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>CRème Auto-bronzante Bronze Dore SPF 15</name>
      <labeller>Laboratoires Clarins</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02239848</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1999-06-11</started-marketing-on>
      <ended-marketing-on>2000-08-22</ended-marketing-on>
      <dosage-form>Emulsion</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Creme Ecran Total Intolerances Solaires SPF 40</name>
      <labeller>Lancome Canada</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02233713</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1998-03-16</started-marketing-on>
      <ended-marketing-on>2004-07-26</ended-marketing-on>
      <dosage-form>Cream</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Creme Ecran Total Intolerances Solaires SPF 45</name>
      <labeller>Vichy Canada</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02229884</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1997-05-13</started-marketing-on>
      <ended-marketing-on>2009-11-03</ended-marketing-on>
      <dosage-form>Cream</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Creme Protectrice Spf15</name>
      <labeller>Lancome Canada</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02205939</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1996-06-27</started-marketing-on>
      <ended-marketing-on>1998-06-09</ended-marketing-on>
      <dosage-form>Cream</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Creme Solaire Bronzage Securite Special Visage SPF 15</name>
      <labeller>Laboratoires Clarins</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02238979</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1998-11-23</started-marketing-on>
      <ended-marketing-on>1999-03-29</ended-marketing-on>
      <dosage-form>Cream</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>CRème Solaire Bronzage Sécurité Spécial Visage SPF 15</name>
      <labeller>Laboratoires Clarins</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02239850</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1999-06-11</started-marketing-on>
      <ended-marketing-on>2002-07-10</ended-marketing-on>
      <dosage-form>Emulsion</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Creme Solaire Ecran Special Visage SPF 30</name>
      <labeller>Laboratoires Clarins</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02238977</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1998-11-23</started-marketing-on>
      <ended-marketing-on>1999-03-29</ended-marketing-on>
      <dosage-form>Cream</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Creme Solaire Haute Protection SPF 15</name>
      <labeller>Lancome Canada</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02233716</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1998-03-16</started-marketing-on>
      <ended-marketing-on>2004-07-26</ended-marketing-on>
      <dosage-form>Cream</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Daily Defense Sunblock</name>
      <labeller>Humex,Inc.</labeller>
      <ndc-id/>
      <ndc-product-code>76344-1001</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2013-04-22</started-marketing-on>
      <ended-marketing-on>2014-01-01</ended-marketing-on>
      <dosage-form>Cream</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number>part352</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Écran Solaire Spécial Rides SPF 15</name>
      <labeller>Biotherm Canada</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02241669</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2000-07-01</started-marketing-on>
      <ended-marketing-on>2004-07-26</ended-marketing-on>
      <dosage-form>Cream</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Ecran Solaire SPF 15 - Crm</name>
      <labeller>Biotherm Canada</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02159473</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1995-12-31</started-marketing-on>
      <ended-marketing-on>2001-07-27</ended-marketing-on>
      <dosage-form>Cream</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Ecran Total Anti-intolerance SPF 30-crm</name>
      <labeller>Biotherm Canada</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02159422</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1995-12-31</started-marketing-on>
      <ended-marketing-on>2001-07-27</ended-marketing-on>
      <dosage-form>Cream</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Écran Total Anti-intolérances Solaires Fps 30</name>
      <labeller>Biotherm Canada</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02242090</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2000-07-01</started-marketing-on>
      <ended-marketing-on>2004-07-26</ended-marketing-on>
      <dosage-form>Cream</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Ecran Total Solaire Fps 25</name>
      <labeller>Biotherm Canada</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02159414</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1995-12-31</started-marketing-on>
      <ended-marketing-on>2001-07-27</ended-marketing-on>
      <dosage-form>Cream</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Écran Total Solaire SPF 25</name>
      <labeller>Biotherm Canada</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02241667</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2000-07-01</started-marketing-on>
      <ended-marketing-on>2004-07-26</ended-marketing-on>
      <dosage-form>Cream</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Gel Creme Protecteur SPF 15</name>
      <labeller>Vichy Canada</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02230189</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1997-05-13</started-marketing-on>
      <ended-marketing-on>2000-06-09</ended-marketing-on>
      <dosage-form>Cream</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Gelee Fraiche Bronz.hydratante SPF 8</name>
      <labeller>Biotherm Canada</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02159457</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1995-12-31</started-marketing-on>
      <ended-marketing-on>2001-07-27</ended-marketing-on>
      <dosage-form>Gel</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Gelée Fraîche Bronzante Hydratante Fps 8</name>
      <labeller>Biotherm Canada</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02242089</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2000-07-01</started-marketing-on>
      <ended-marketing-on>2004-07-26</ended-marketing-on>
      <dosage-form>Gel</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Gelee Fraicheur Bronzage Eclat SPF 8</name>
      <labeller>Lancome Canada</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02233714</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1998-03-16</started-marketing-on>
      <ended-marketing-on>2001-05-29</ended-marketing-on>
      <dosage-form>Gel</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Glamtox SPF 18</name>
      <labeller>Rodial</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02358379</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on/>
      <ended-marketing-on/>
      <dosage-form>Lotion</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Lait Ecran Extreme SPF 60</name>
      <labeller>Vichy Canada</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02241260</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2000-04-01</started-marketing-on>
      <ended-marketing-on>2008-07-23</ended-marketing-on>
      <dosage-form>Cream</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Lait Écran Total SPF 25</name>
      <labeller>Biotherm Canada</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02241668</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2000-07-01</started-marketing-on>
      <ended-marketing-on>2004-07-26</ended-marketing-on>
      <dosage-form>Cream</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Lait Protecteur Hydro-satinant Spf15</name>
      <labeller>Lancome Canada</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02207575</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1996-12-31</started-marketing-on>
      <ended-marketing-on>1998-06-09</ended-marketing-on>
      <dosage-form>Lotion</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Lait Solaire Ecran Total SPF 25</name>
      <labeller>Lancome Canada</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02233715</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1998-03-16</started-marketing-on>
      <ended-marketing-on>2004-07-26</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Lait Solaire Haute Protection SPF 15</name>
      <labeller>Lancome Canada</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02233717</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1998-03-30</started-marketing-on>
      <ended-marketing-on>2004-07-26</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Lancome Creme Ecran Total SPF 25</name>
      <labeller>Lancome Canada</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02165848</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1995-12-31</started-marketing-on>
      <ended-marketing-on>1998-06-09</ended-marketing-on>
      <dosage-form>Cream</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Lancome Lait Ecran Total Hydro-satin.spf25</name>
      <labeller>Lancome Canada</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02165856</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1995-12-31</started-marketing-on>
      <ended-marketing-on>1998-06-09</ended-marketing-on>
      <dosage-form>Lotion</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Lancome-creme Autobronzante Visage Crm</name>
      <labeller>Lancome Canada</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02058995</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1994-12-31</started-marketing-on>
      <ended-marketing-on>1998-06-09</ended-marketing-on>
      <dosage-form>Cream</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Laser Block 100 sunblock</name>
      <labeller>Universal Cosmetic Co., Ltd</labeller>
      <ndc-id/>
      <ndc-product-code>52554-3001</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2010-08-04</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Cream</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Lotion Sport</name>
      <labeller>Laboratoires Confab Inc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02290103</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2007-04-05</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Lotion</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>MediSpa Sunblock sunblock</name>
      <labeller>Universal Cosmetic Co., Ltd</labeller>
      <ndc-id/>
      <ndc-product-code>52554-1001</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2010-08-04</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Cream</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>MediSpa SunSpray sunblock</name>
      <labeller>Universal Cosmetic Co., Ltd</labeller>
      <ndc-id/>
      <ndc-product-code>52554-2001</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2010-08-06</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Spray</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>mesoestetic moisturizing sun protection BROAD SPECTRUM FOR NORMAL AND DRY SKINS</name>
      <labeller>Mesoestetic, S.L.</labeller>
      <ndc-id/>
      <ndc-product-code>76450-052</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2012-02-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Cream</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number>part352</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Mesoestetic Sun Protection SPF 30</name>
      <labeller>Tylstin Medical</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02318911</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2009-07-13</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Cream</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Moisturising Sun Protection Spf50</name>
      <labeller>Mesoestetic, S.L.</labeller>
      <ndc-id/>
      <ndc-product-code>76450-050</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2012-02-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Lotion</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number>part352</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Natural Sun AQ Body and Family Mild Sun Milk</name>
      <labeller>Thefaceshop Co., Ltd.</labeller>
      <ndc-id/>
      <ndc-product-code>51523-101</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2010-11-22</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Cream</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number>part352</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Natural Sun AQ Total Anti-aging Essence Sun</name>
      <labeller>Thefaceshop Co., Ltd.</labeller>
      <ndc-id/>
      <ndc-product-code>51523-102</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2010-11-22</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Cream</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number>part352</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Nwc 21 Natural Premium Bb Cream</name>
      <labeller>Cleansia Corporation Ltd.</labeller>
      <ndc-id/>
      <ndc-product-code>45167-451</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2010-01-21</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Cream</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number>part352</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Ombrelle - Lotion Spf30</name>
      <labeller>Cosmair Canada Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02241366</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2000-05-01</started-marketing-on>
      <ended-marketing-on>2003-07-23</ended-marketing-on>
      <dosage-form>Cream</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Ombrelle Creme Ecran SPF 60</name>
      <labeller>Cosmair Canada Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02239144</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1999-03-01</started-marketing-on>
      <ended-marketing-on>2008-11-03</ended-marketing-on>
      <dosage-form>Cream</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Ombrelle Lotion SPF 30</name>
      <labeller>Cosmair Canada Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02192772</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1996-12-31</started-marketing-on>
      <ended-marketing-on>2001-07-27</ended-marketing-on>
      <dosage-form>Lotion</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Ombrelle Lotion SPF 30 Pour Enfants</name>
      <labeller>Cosmair Canada Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02148862</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1995-12-31</started-marketing-on>
      <ended-marketing-on>2001-07-27</ended-marketing-on>
      <dosage-form>Lotion</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Ombrelle-lotion Spf15</name>
      <labeller>L'oreal</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02243505</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2001-03-08</started-marketing-on>
      <ended-marketing-on>2003-07-23</ended-marketing-on>
      <dosage-form>Lotion</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Outback 2-in-1 Insect Repellent and Protective Sunscreen</name>
      <labeller>Elmore Oil Company Pty Ltd</labeller>
      <ndc-id/>
      <ndc-product-code>43979-445</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2012-07-01</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Cream</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Qt Sun Block</name>
      <labeller>Cleansia Corporation Ltd.</labeller>
      <ndc-id/>
      <ndc-product-code>45167-516</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2010-01-21</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Cream</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number>part352</fda-application-number>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>R.P. Sol</name>
      <labeller>Laboratoire Diametiss</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02242644</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2001-02-01</started-marketing-on>
      <ended-marketing-on>2011-03-16</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Rejuva Moisturizing Day Cream SPF 30</name>
      <labeller>Glaxosmithkline Inc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02237874</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2000-10-23</started-marketing-on>
      <ended-marketing-on>2014-05-01</ended-marketing-on>
      <dosage-form>Cream</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Roc Minesol Protect Ultra High Protection Suncare Cream SPF 60</name>
      <labeller>Johnson &amp; Johnson</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02288524</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2007-04-13</started-marketing-on>
      <ended-marketing-on>2014-07-30</ended-marketing-on>
      <dosage-form>Cream</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Sebamed SPF 25 Lip Defense</name>
      <labeller>Lofco Canada Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02248434</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2004-03-15</started-marketing-on>
      <ended-marketing-on>2007-08-01</ended-marketing-on>
      <dosage-form>Cream</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Sebamed Sun Cream SPF 16</name>
      <labeller>Lofco Canada Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02240486</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2000-04-17</started-marketing-on>
      <ended-marketing-on>2005-07-15</ended-marketing-on>
      <dosage-form>Cream</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Sebamed Sun Cream SPF 20</name>
      <labeller>Lofco Canada Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02240487</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2000-04-17</started-marketing-on>
      <ended-marketing-on>2005-07-15</ended-marketing-on>
      <dosage-form>Cream</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Sebamed Sun Cream SPF 8</name>
      <labeller>Lofco Canada Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02240482</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2000-04-17</started-marketing-on>
      <ended-marketing-on>2004-08-02</ended-marketing-on>
      <dosage-form>Cream</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Sebamed Sun Lotion SPF 16</name>
      <labeller>Lofco Canada Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02240489</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2000-04-17</started-marketing-on>
      <ended-marketing-on>2007-08-01</ended-marketing-on>
      <dosage-form>Lotion</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Sebamed Sun Lotion SPF 20</name>
      <labeller>Lofco Canada Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02240490</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2000-04-17</started-marketing-on>
      <ended-marketing-on>2007-08-01</ended-marketing-on>
      <dosage-form>Lotion</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Sebamed Sun Lotion SPF 8</name>
      <labeller>Lofco Canada Inc.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02240488</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2000-04-17</started-marketing-on>
      <ended-marketing-on>2004-08-02</ended-marketing-on>
      <dosage-form>Lotion</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Secret Key Natural Cc Cushion Spf50 Pa / 02 Natural Cc</name>
      <labeller>Zenpia</labeller>
      <ndc-id/>
      <ndc-product-code>70825-0011</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2015-07-05</started-marketing-on>
      <ended-marketing-on>2016-08-01</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Secret Key Natural Cc Cushion Spf50 Plus / 01 Light Cc</name>
      <labeller>Zenpia</labeller>
      <ndc-id/>
      <ndc-product-code>70825-0010</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2015-07-05</started-marketing-on>
      <ended-marketing-on>2018-12-19</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Secret Key Natural Cc Cushion Spf50 Plus / 02 Natural Cc</name>
      <labeller>Zenpia</labeller>
      <ndc-id/>
      <ndc-product-code>70825-0012</ndc-product-code>
      <dpd-id/>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2015-07-05</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>false</approved>
      <country>US</country>
      <source>FDA NDC</source>
    </product>
    <product>
      <name>Snik - Lot</name>
      <labeller>Austria Import West Ltd.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02227290</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1997-09-29</started-marketing-on>
      <ended-marketing-on>2007-07-26</ended-marketing-on>
      <dosage-form>Lotion</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Snik Crm 6%</name>
      <labeller>Austria Import West Ltd.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02061155</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1997-09-10</started-marketing-on>
      <ended-marketing-on>2003-07-29</ended-marketing-on>
      <dosage-form>Cream</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Snik Lotion SPF 15</name>
      <labeller>Austria Import West Ltd.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02237031</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1998-06-24</started-marketing-on>
      <ended-marketing-on>2007-07-26</ended-marketing-on>
      <dosage-form>Lotion</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Snik Lotion SPF 38</name>
      <labeller>Austria Import West Ltd.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02237032</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1998-06-24</started-marketing-on>
      <ended-marketing-on>2007-07-26</ended-marketing-on>
      <dosage-form>Lotion</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Snik Sun Milk - Crm</name>
      <labeller>Austria Import West Ltd.</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02227304</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1998-12-22</started-marketing-on>
      <ended-marketing-on>2007-07-26</ended-marketing-on>
      <dosage-form>Cream</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Soin Solaire Autobronzant SPF 8 - Crm</name>
      <labeller>Biotherm Canada</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02159406</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1995-12-31</started-marketing-on>
      <ended-marketing-on>2003-07-23</ended-marketing-on>
      <dosage-form>Cream</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Soleil Protexion Velvet Moisture SPF 30</name>
      <labeller>Johnson &amp; Johnson</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02288540</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2007-04-13</started-marketing-on>
      <ended-marketing-on>2014-07-30</ended-marketing-on>
      <dosage-form>Spray</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Soleil Protexion Velvet Moisture SPF 60</name>
      <labeller>Johnson &amp; Johnson</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02288532</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>2007-04-13</started-marketing-on>
      <ended-marketing-on>2013-07-31</ended-marketing-on>
      <dosage-form>Spray</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Sunscreen Lotion Ecran Solaire 30</name>
      <labeller>Laboratoires Confab Inc</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02230861</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1997-11-10</started-marketing-on>
      <ended-marketing-on/>
      <dosage-form>Lotion</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Vichy Creme Ecran Total Intol.soc. SPF 30</name>
      <labeller>Vichy Canada</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02156520</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1995-12-31</started-marketing-on>
      <ended-marketing-on>1997-05-20</ended-marketing-on>
      <dosage-form>Cream</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Vichy Lait Ecran Total Intoler.sol. SPF 30</name>
      <labeller>Vichy Canada</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02156539</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1995-12-31</started-marketing-on>
      <ended-marketing-on>1997-05-20</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Vichy Lait Ecran Total Special Enf.SPF 25</name>
      <labeller>Vichy Canada</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02156547</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1995-12-31</started-marketing-on>
      <ended-marketing-on>1997-05-20</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Vichy Lait Hydratant Bronzage Progresif Spf8</name>
      <labeller>Vichy Canada</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02155060</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1995-12-31</started-marketing-on>
      <ended-marketing-on>1997-05-20</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Vichy Lait Protecteur SPF 15</name>
      <labeller>Vichy Canada</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02157373</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1995-12-31</started-marketing-on>
      <ended-marketing-on>1997-05-20</ended-marketing-on>
      <dosage-form>Liquid</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Vichy-creme Ecran Total SPF 25</name>
      <labeller>Vichy Canada</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02096986</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1995-12-31</started-marketing-on>
      <ended-marketing-on>1997-05-20</ended-marketing-on>
      <dosage-form>Cream</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Vichy-creme Haute Protection SPF 15</name>
      <labeller>Vichy Canada</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02097044</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1995-12-31</started-marketing-on>
      <ended-marketing-on>1997-05-20</ended-marketing-on>
      <dosage-form>Cream</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
    <product>
      <name>Vichy-lait Ecran Total SPF 25</name>
      <labeller>Vichy Canada</labeller>
      <ndc-id/>
      <ndc-product-code/>
      <dpd-id>02096994</dpd-id>
      <ema-product-code/>
      <ema-ma-number/>
      <started-marketing-on>1995-12-31</started-marketing-on>
      <ended-marketing-on>1997-05-20</ended-marketing-on>
      <dosage-form>Lotion</dosage-form>
      <strength/>
      <route>Topical</route>
      <fda-application-number/>
      <generic>false</generic>
      <over-the-counter>true</over-the-counter>
      <approved>true</approved>
      <country>Canada</country>
      <source>DPD</source>
    </product>
  </products>
  <international-brands/>
  <mixtures>
    <mixture>
      <name>Natural Sun AQ Total Anti-aging Essence Sun</name>
      <ingredients>Adenosine + Avobenzone + Enzacamene + Nicotinamide + Octinoxate + Octisalate + Titanium dioxide</ingredients>
    </mixture>
    <mixture>
      <name>Natural Sun AQ Body and Family Mild Sun Milk</name>
      <ingredients>Avobenzone + Enzacamene + Octinoxate + Octisalate + Titanium dioxide</ingredients>
    </mixture>
    <mixture>
      <name>Correway Sunscreen (Waterproof)</name>
      <ingredients>Avobenzone + Enzacamene + Octinoxate + Zinc oxide</ingredients>
    </mixture>
    <mixture>
      <name>Nwc 21 Natural Premium Bb Cream</name>
      <ingredients>Enzacamene + Octinoxate + Titanium dioxide</ingredients>
    </mixture>
    <mixture>
      <name>MediSpa SunSpray sunblock</name>
      <ingredients>Enzacamene + Octinoxate + Octocrylene</ingredients>
    </mixture>
    <mixture>
      <name>Laser Block 100 sunblock</name>
      <ingredients>Amiloxate + Avobenzone + Enzacamene + Octinoxate + Titanium dioxide + Zinc oxide</ingredients>
    </mixture>
    <mixture>
      <name>MediSpa Sunblock sunblock</name>
      <ingredients>Avobenzone + Enzacamene + Octinoxate + Zinc oxide</ingredients>
    </mixture>
    <mixture>
      <name>Qt Sun Block</name>
      <ingredients>Enzacamene + Octinoxate + Titanium dioxide</ingredients>
    </mixture>
    <mixture>
      <name>Conju Princess UV Sun Block</name>
      <ingredients>Avobenzone + Enzacamene + Octinoxate + Titanium dioxide + Zinc oxide</ingredients>
    </mixture>
    <mixture>
      <name>Conju Princess UV Sun Block</name>
      <ingredients>Avobenzone + Enzacamene + Octinoxate + Titanium dioxide + Zinc oxide</ingredients>
    </mixture>
    <mixture>
      <name>Outback 2-in-1 Insect Repellent and Protective Sunscreen</name>
      <ingredients>Enzacamene + Octinoxate + Zinc oxide</ingredients>
    </mixture>
    <mixture>
      <name>Daily Defense Sunblock</name>
      <ingredients>Amiloxate + Avobenzone + Enzacamene + Octinoxate + Titanium dioxide + Zinc oxide</ingredients>
    </mixture>
    <mixture>
      <name>Secret Key Natural Cc Cushion Spf50 Plus / 02 Natural Cc</name>
      <ingredients>Enzacamene + Octinoxate + Octisalate + Titanium dioxide</ingredients>
    </mixture>
    <mixture>
      <name>Secret Key Natural Cc Cushion Spf50 Pa / 02 Natural Cc</name>
      <ingredients>Enzacamene + Octinoxate + Octisalate + Titanium dioxide</ingredients>
    </mixture>
    <mixture>
      <name>Secret Key Natural Cc Cushion Spf50 Plus / 01 Light Cc</name>
      <ingredients>Enzacamene + Octinoxate + Octisalate + Titanium dioxide</ingredients>
    </mixture>
    <mixture>
      <name>Moisturising Sun Protection Spf50</name>
      <ingredients>Avobenzone + Ensulizole + Enzacamene + Octinoxate</ingredients>
    </mixture>
    <mixture>
      <name>mesoestetic moisturizing sun protection BROAD SPECTRUM FOR NORMAL AND DRY SKINS</name>
      <ingredients>Avobenzone + Ensulizole + Enzacamene + Octinoxate</ingredients>
    </mixture>
    <mixture>
      <name>But First Water</name>
      <ingredients>Enzacamene + Octinoxate + Titanium dioxide + Zinc oxide</ingredients>
    </mixture>
    <mixture>
      <name>Mesoestetic Sun Protection SPF 30</name>
      <ingredients>Avobenzone + Ensulizole + Enzacamene + Octinoxate</ingredients>
    </mixture>
    <mixture>
      <name>Lancome-creme Autobronzante Visage Crm</name>
      <ingredients>Avobenzone + Enzacamene</ingredients>
    </mixture>
    <mixture>
      <name>Soin Solaire Autobronzant SPF 8 - Crm</name>
      <ingredients>Avobenzone + Ecamsule + Enzacamene</ingredients>
    </mixture>
    <mixture>
      <name>Vichy Lait Hydratant Bronzage Progresif Spf8</name>
      <ingredients>Avobenzone + Ecamsule + Enzacamene + Titanium dioxide</ingredients>
    </mixture>
    <mixture>
      <name>Vichy-lait Ecran Total SPF 25</name>
      <ingredients>Avobenzone + Ecamsule + Enzacamene + Titanium dioxide</ingredients>
    </mixture>
    <mixture>
      <name>Vichy Lait Ecran Total Special Enf.SPF 25</name>
      <ingredients>Avobenzone + Ecamsule + Enzacamene + Titanium dioxide</ingredients>
    </mixture>
    <mixture>
      <name>Vichy Creme Ecran Total Intol.soc. SPF 30</name>
      <ingredients>Avobenzone + Ecamsule + Enzacamene + Titanium dioxide</ingredients>
    </mixture>
    <mixture>
      <name>Vichy-creme Haute Protection SPF 15</name>
      <ingredients>Avobenzone + Ecamsule + Enzacamene + Titanium dioxide</ingredients>
    </mixture>
    <mixture>
      <name>Vichy-creme Ecran Total SPF 25</name>
      <ingredients>Avobenzone + Ecamsule + Enzacamene + Titanium dioxide</ingredients>
    </mixture>
    <mixture>
      <name>Vichy Lait Ecran Total Intoler.sol. SPF 30</name>
      <ingredients>Avobenzone + Ecamsule + Enzacamene + Titanium dioxide</ingredients>
    </mixture>
    <mixture>
      <name>Vichy Lait Protecteur SPF 15</name>
      <ingredients>Avobenzone + Ecamsule + Enzacamene + Titanium dioxide</ingredients>
    </mixture>
    <mixture>
      <name>Ecran Solaire SPF 15 - Crm</name>
      <ingredients>Avobenzone + Ecamsule + Enzacamene + Titanium dioxide</ingredients>
    </mixture>
    <mixture>
      <name>Gelee Fraiche Bronz.hydratante SPF 8</name>
      <ingredients>Ecamsule + Enzacamene + Octinoxate + Titanium dioxide</ingredients>
    </mixture>
    <mixture>
      <name>Ecran Total Solaire Fps 25</name>
      <ingredients>Avobenzone + Ecamsule + Enzacamene + Titanium dioxide</ingredients>
    </mixture>
    <mixture>
      <name>Ecran Total Anti-intolerance SPF 30-crm</name>
      <ingredients>Avobenzone + Ecamsule + Enzacamene + Titanium dioxide</ingredients>
    </mixture>
    <mixture>
      <name>Lancome Lait Ecran Total Hydro-satin.spf25</name>
      <ingredients>Avobenzone + Ecamsule + Enzacamene + Titanium dioxide</ingredients>
    </mixture>
    <mixture>
      <name>Lancome Creme Ecran Total SPF 25</name>
      <ingredients>Avobenzone + Ecamsule + Enzacamene + Titanium dioxide</ingredients>
    </mixture>
    <mixture>
      <name>Lait Protecteur Hydro-satinant Spf15</name>
      <ingredients>Avobenzone + Ecamsule + Enzacamene + Titanium dioxide</ingredients>
    </mixture>
    <mixture>
      <name>Creme Protectrice Spf15</name>
      <ingredients>Avobenzone + Ecamsule + Enzacamene + Titanium dioxide</ingredients>
    </mixture>
    <mixture>
      <name>Biotherm - Lait Ecran Total SPF 25</name>
      <ingredients>Avobenzone + Ecamsule + Enzacamene + Titanium dioxide</ingredients>
    </mixture>
    <mixture>
      <name>Antherpos-ceralip Solaire SPF 50</name>
      <ingredients>Avobenzone + Ecamsule + Enzacamene + Titanium dioxide</ingredients>
    </mixture>
    <mixture>
      <name>Anthelios L-lait Ecran Intol.solaire SPF 60</name>
      <ingredients>Avobenzone + Ecamsule + Enzacamene + Titanium dioxide</ingredients>
    </mixture>
    <mixture>
      <name>Anthelios-stick Ecran SPF 30</name>
      <ingredients>Avobenzone + Enzacamene</ingredients>
    </mixture>
    <mixture>
      <name>Anthelios-lait Ecran Invisible SPF 20</name>
      <ingredients>Avobenzone + Ecamsule + Enzacamene + Titanium dioxide</ingredients>
    </mixture>
    <mixture>
      <name>Anthelios-ecran Invisible SPF 20</name>
      <ingredients>Avobenzone + Ecamsule + Enzacamene + Titanium dioxide</ingredients>
    </mixture>
    <mixture>
      <name>Anthelios-creme Solaire SPF 10</name>
      <ingredients>Avobenzone + Ecamsule + Enzacamene + Titanium dioxide</ingredients>
    </mixture>
    <mixture>
      <name>Snik Crm 6%</name>
      <ingredients>Enzacamene</ingredients>
    </mixture>
    <mixture>
      <name>Snik - Lot</name>
      <ingredients>Avobenzone + Enzacamene</ingredients>
    </mixture>
    <mixture>
      <name>Snik Sun Milk - Crm</name>
      <ingredients>Avobenzone + Enzacamene</ingredients>
    </mixture>
    <mixture>
      <name>Ombrelle Lotion SPF 30 Pour Enfants</name>
      <ingredients>Avobenzone + Ensulizole + Enzacamene + Octinoxate</ingredients>
    </mixture>
    <mixture>
      <name>Ombrelle Lotion SPF 30</name>
      <ingredients>Avobenzone + Ensulizole + Enzacamene + Octinoxate</ingredients>
    </mixture>
    <mixture>
      <name>Bain De Soleil Protection Lotion SPF 15</name>
      <ingredients>Avobenzone + Enzacamene + Octisalate + Titanium dioxide</ingredients>
    </mixture>
    <mixture>
      <name>Creme Ecran Total Intolerances Solaires SPF 45</name>
      <ingredients>Avobenzone + Ecamsule + Enzacamene + Titanium dioxide</ingredients>
    </mixture>
    <mixture>
      <name>Gel Creme Protecteur SPF 15</name>
      <ingredients>Avobenzone + Ecamsule + Enzacamene + Titanium dioxide</ingredients>
    </mixture>
    <mixture>
      <name>Anthelios S - Ecran Solaire SPF 30</name>
      <ingredients>Avobenzone + Ecamsule + Enzacamene + Titanium dioxide</ingredients>
    </mixture>
    <mixture>
      <name>Biokids SPF 35</name>
      <ingredients>Avobenzone + Ecamsule + Enzacamene + Octocrylene + Titanium dioxide</ingredients>
    </mixture>
    <mixture>
      <name>Creme Ecran Total Intolerances Solaires SPF 40</name>
      <ingredients>Avobenzone + Ecamsule + Enzacamene + Titanium dioxide</ingredients>
    </mixture>
    <mixture>
      <name>Gelee Fraicheur Bronzage Eclat SPF 8</name>
      <ingredients>Ecamsule + Enzacamene + Octinoxate + Titanium dioxide</ingredients>
    </mixture>
    <mixture>
      <name>Lait Solaire Ecran Total SPF 25</name>
      <ingredients>Avobenzone + Ecamsule + Enzacamene + Titanium dioxide</ingredients>
    </mixture>
    <mixture>
      <name>Creme Solaire Haute Protection SPF 15</name>
      <ingredients>Avobenzone + Ecamsule + Enzacamene + Titanium dioxide</ingredients>
    </mixture>
    <mixture>
      <name>Lait Solaire Haute Protection SPF 15</name>
      <ingredients>Avobenzone + Ecamsule + Enzacamene + Octocrylene + Titanium dioxide</ingredients>
    </mixture>
    <mixture>
      <name>Snik Lotion SPF 15</name>
      <ingredients>Avobenzone + Enzacamene</ingredients>
    </mixture>
    <mixture>
      <name>Snik Lotion SPF 38</name>
      <ingredients>Avobenzone + Enzacamene</ingredients>
    </mixture>
    <mixture>
      <name>Anthelios L - Ecran Intolerances Solaires SPF 60</name>
      <ingredients>Avobenzone + Ecamsule + Enzacamene + Titanium dioxide</ingredients>
    </mixture>
    <mixture>
      <name>Rejuva Moisturizing Day Cream SPF 30</name>
      <ingredients>Avobenzone + Enzacamene + Octinoxate</ingredients>
    </mixture>
    <mixture>
      <name>Creme Auto-bronzante Bronze Dore SPF 15</name>
      <ingredients>Avobenzone + Enzacamene + Oxybenzone</ingredients>
    </mixture>
    <mixture>
      <name>Creme Solaire Ecran Special Visage SPF 30</name>
      <ingredients>Avobenzone + Ensulizole + Enzacamene + Octinoxate + Oxybenzone + Titanium dioxide</ingredients>
    </mixture>
    <mixture>
      <name>Creme Solaire Bronzage Securite Special Visage SPF 15</name>
      <ingredients>Avobenzone + Enzacamene + Oxybenzone</ingredients>
    </mixture>
    <mixture>
      <name>Ombrelle Creme Ecran SPF 60</name>
      <ingredients>Avobenzone + Ecamsule + Enzacamene + Titanium dioxide</ingredients>
    </mixture>
    <mixture>
      <name>Autobronzant SPF 7</name>
      <ingredients>Avobenzone + Ecamsule + Enzacamene</ingredients>
    </mixture>
    <mixture>
      <name>CRème Auto-bronzante Bronze Dore SPF 15</name>
      <ingredients>Avobenzone + Enzacamene + Octinoxate + Oxybenzone</ingredients>
    </mixture>
    <mixture>
      <name>CRème Solaire Bronzage Sécurité Spécial Visage SPF 15</name>
      <ingredients>Avobenzone + Enzacamene + Octinoxate + Oxybenzone</ingredients>
    </mixture>
    <mixture>
      <name>Sebamed Sun Cream SPF 8</name>
      <ingredients>Avobenzone + Enzacamene + Octinoxate + Sulisobenzone</ingredients>
    </mixture>
    <mixture>
      <name>Sebamed Sun Cream SPF 16</name>
      <ingredients>Avobenzone + Enzacamene + Octinoxate + Sulisobenzone</ingredients>
    </mixture>
    <mixture>
      <name>Sebamed Sun Cream SPF 20</name>
      <ingredients>Avobenzone + Enzacamene + Octinoxate + Sulisobenzone</ingredients>
    </mixture>
    <mixture>
      <name>Sebamed Sun Lotion SPF 8</name>
      <ingredients>Avobenzone + Enzacamene + Octinoxate + Sulisobenzone</ingredients>
    </mixture>
    <mixture>
      <name>Sebamed Sun Lotion SPF 16</name>
      <ingredients>Avobenzone + Enzacamene + Octinoxate + Sulisobenzone</ingredients>
    </mixture>
    <mixture>
      <name>Sebamed Sun Lotion SPF 20</name>
      <ingredients>Avobenzone + Enzacamene + Octinoxate + Sulisobenzone</ingredients>
    </mixture>
    <mixture>
      <name>Lait Ecran Extreme SPF 60</name>
      <ingredients>Avobenzone + Ecamsule + Enzacamene + Titanium dioxide</ingredients>
    </mixture>
    <mixture>
      <name>Ombrelle - Lotion Spf30</name>
      <ingredients>Avobenzone + Ecamsule + Ensulizole + Enzacamene + Octocrylene</ingredients>
    </mixture>
    <mixture>
      <name>Écran Total Solaire SPF 25</name>
      <ingredients>Avobenzone + Ecamsule + Enzacamene + Titanium dioxide</ingredients>
    </mixture>
    <mixture>
      <name>Lait Écran Total SPF 25</name>
      <ingredients>Avobenzone + Ecamsule + Enzacamene + Titanium dioxide</ingredients>
    </mixture>
    <mixture>
      <name>Écran Solaire Spécial Rides SPF 15</name>
      <ingredients>Avobenzone + Ecamsule + Enzacamene + Titanium dioxide</ingredients>
    </mixture>
    <mixture>
      <name>Gelée Fraîche Bronzante Hydratante Fps 8</name>
      <ingredients>Ecamsule + Enzacamene + Octinoxate + Titanium dioxide</ingredients>
    </mixture>
    <mixture>
      <name>Écran Total Anti-intolérances Solaires Fps 30</name>
      <ingredients>Avobenzone + Ecamsule + Enzacamene + Titanium dioxide</ingredients>
    </mixture>
    <mixture>
      <name>R.P. Sol</name>
      <ingredients>Avobenzone + Enzacamene + Octinoxate + Oxybenzone</ingredients>
    </mixture>
    <mixture>
      <name>Ombrelle-lotion Spf15</name>
      <ingredients>Avobenzone + Ecamsule + Enzacamene + Octocrylene</ingredients>
    </mixture>
    <mixture>
      <name>Autobronzant Creme Fps 15</name>
      <ingredients>Avobenzone + Ecamsule + Enzacamene + Octocrylene</ingredients>
    </mixture>
    <mixture>
      <name>Sebamed SPF 25 Lip Defense</name>
      <ingredients>Avobenzone + Enzacamene + Octinoxate</ingredients>
    </mixture>
    <mixture>
      <name>Roc Minesol Protect Ultra High Protection Suncare Cream SPF 60</name>
      <ingredients>Bemotrizinol + Bisoctrizole + Enzacamene + Octinoxate + Titanium dioxide</ingredients>
    </mixture>
    <mixture>
      <name>Soleil Protexion Velvet Moisture SPF 60</name>
      <ingredients>Bemotrizinol + Bisoctrizole + Enzacamene + Octinoxate + Titanium dioxide</ingredients>
    </mixture>
    <mixture>
      <name>Soleil Protexion Velvet Moisture SPF 30</name>
      <ingredients>Bemotrizinol + Bisoctrizole + Enzacamene + Octinoxate</ingredients>
    </mixture>
    <mixture>
      <name>Sunscreen Lotion Ecran Solaire 30</name>
      <ingredients>Avobenzone + Ensulizole + Enzacamene + Octinoxate</ingredients>
    </mixture>
    <mixture>
      <name>Lotion Sport</name>
      <ingredients>Avobenzone + Ensulizole + Enzacamene + Octinoxate</ingredients>
    </mixture>
    <mixture>
      <name>Glamtox SPF 18</name>
      <ingredients>Avobenzone + Enzacamene + Octinoxate</ingredients>
    </mixture>
  </mixtures>
  <packagers/>
  <manufacturers/>
  <prices/>
  <categories>
    <category>
      <category>Bornanes</category>
      <mesh-id>D001892</mesh-id>
    </category>
    <category>
      <category>Ketones</category>
      <mesh-id>D007659</mesh-id>
    </category>
    <category>
      <category>Monoterpenes</category>
      <mesh-id>D039821</mesh-id>
    </category>
    <category>
      <category>Norbornanes</category>
      <mesh-id>D009636</mesh-id>
    </category>
    <category>
      <category>Sunscreen Agents</category>
      <mesh-id>D013473</mesh-id>
    </category>
    <category>
      <category>Terpenes</category>
      <mesh-id>D013729</mesh-id>
    </category>
  </categories>
  <affected-organisms/>
  <dosages>
    <dosage>
      <form>Stick</form>
      <route>Topical</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Emulsion</form>
      <route>Topical</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Gel</form>
      <route>Topical</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Spray</form>
      <route>Topical</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Lotion</form>
      <route>Topical</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Cream</form>
      <route>Topical</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Liquid</form>
      <route>Topical</route>
      <strength/>
    </dosage>
    <dosage>
      <form>Cream</form>
      <route>Topical</route>
      <strength/>
    </dosage>
  </dosages>
  <atc-codes/>
  <ahfs-codes>
    <ahfs-code>84:80.00</ahfs-code>
  </ahfs-codes>
  <pdb-entries/>
  <msds>//s3-us-west-2.amazonaws.com/drugbank/msds/DB11219.pdf?1525452838</msds>
  <patents/>
  <food-interactions/>
  <drug-interactions/>
  <calculated-properties>
    <property>
      <kind>logP</kind>
      <value>5.09</value>
      <source>ALOGPS</source>
    </property>
    <property>
      <kind>logS</kind>
      <value>-4.7</value>
      <source>ALOGPS</source>
    </property>
    <property>
      <kind>Water Solubility</kind>
      <value>5.10e-03 g/l</value>
      <source>ALOGPS</source>
    </property>
    <property>
      <kind>logP</kind>
      <value>5.12</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>IUPAC Name</kind>
      <value>(3E)-1,7,7-trimethyl-3-[(4-methylphenyl)methylidene]bicyclo[2.2.1]heptan-2-one</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Traditional IUPAC Name</kind>
      <value>4-methylbenzylidene camphor</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Molecular Weight</kind>
      <value>254.373</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Monoisotopic Weight</kind>
      <value>254.167065328</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>SMILES</kind>
      <value>CC1=CC=C(\C=C2/C3CCC(C)(C2=O)C3(C)C)C=C1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Molecular Formula</kind>
      <value>C18H22O</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>InChI</kind>
      <value>InChI=1S/C18H22O/c1-12-5-7-13(8-6-12)11-14-15-9-10-18(4,16(14)19)17(15,2)3/h5-8,11,15H,9-10H2,1-4H3/b14-11+</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>InChIKey</kind>
      <value>HEOCBCNFKCOKBX-SDNWHVSQSA-N</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Polar Surface Area (PSA)</kind>
      <value>17.07</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Refractivity</kind>
      <value>79.68</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Polarizability</kind>
      <value>30.58</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Rotatable Bond Count</kind>
      <value>1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>H Bond Acceptor Count</kind>
      <value>1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>H Bond Donor Count</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>pKa (strongest basic)</kind>
      <value>-5.2</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Physiological Charge</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Number of Rings</kind>
      <value>3</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Bioavailability</kind>
      <value>1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Rule of Five</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>Ghose Filter</kind>
      <value>1</value>
      <source>ChemAxon</source>
    </property>
    <property>
      <kind>MDDR-Like Rule</kind>
      <value>0</value>
      <source>ChemAxon</source>
    </property>
  </calculated-properties>
  <experimental-properties>
    <property>
      <kind>Water Solubility</kind>
      <value>Poorly soluble</value>
      <source>European Commission SCCP: Opinion on 4-methylbenzylidene camphor (4-MBC)</source>
    </property>
    <property>
      <kind>Melting Point</kind>
      <value>66-69</value>
      <source>European Commission SCCP: Opinion on 4-methylbenzylidene camphor (4-MBC)</source>
    </property>
    <property>
      <kind>logP</kind>
      <value>5.14</value>
      <source>European Commission SCCP: Opinion on 4-methylbenzylidene camphor (4-MBC)</source>
    </property>
  </experimental-properties>
  <external-identifiers>
    <external-identifier>
      <resource>Drugs Product Database (DPD)</resource>
      <identifier>20039</identifier>
    </external-identifier>
    <external-identifier>
      <resource>ChEBI</resource>
      <identifier>135937</identifier>
    </external-identifier>
    <external-identifier>
      <resource>PubChem Compound</resource>
      <identifier>7019255</identifier>
    </external-identifier>
    <external-identifier>
      <resource>PubChem Substance</resource>
      <identifier>347827944</identifier>
    </external-identifier>
    <external-identifier>
      <resource>ChemSpider</resource>
      <identifier>4939160</identifier>
    </external-identifier>
    <external-identifier>
      <resource>BindingDB</resource>
      <identifier>50103609</identifier>
    </external-identifier>
    <external-identifier>
      <resource>Wikipedia</resource>
      <identifier>Enzacamene</identifier>
    </external-identifier>
    <external-identifier>
      <resource>ChEMBL</resource>
      <identifier>CHEMBL2104261</identifier>
    </external-identifier>
  </external-identifiers>
  <external-links/>
  <pathways/>
  <reactions>
    <reaction>
      <sequence>1</sequence>
      <left-element>
        <drugbank-id>DB11219</drugbank-id>
        <name>Enzacamene</name>
      </left-element>
      <right-element>
        <drugbank-id>DBMET02091</drugbank-id>
        <name>3-(4-hydroxymethylbenzylidene)camphor</name>
      </right-element>
      <enzymes/>
    </reaction>
    <reaction>
      <sequence>2</sequence>
      <left-element>
        <drugbank-id>DBMET02091</drugbank-id>
        <name>3-(4-hydroxymethylbenzylidene)camphor</name>
      </left-element>
      <right-element>
        <drugbank-id>DBMET02092</drugbank-id>
        <name>3-(4-carboxybenzylidene)camphor</name>
      </right-element>
      <enzymes>
        <enzyme>
          <drugbank-id>BE0004352</drugbank-id>
          <name>Alcohol dehydrogenase [NADP(+)]</name>
          <uniprot-id>P14550</uniprot-id>
        </enzyme>
        <enzyme>
          <drugbank-id>BE0000133</drugbank-id>
          <name>Aldehyde dehydrogenase, mitochondrial</name>
          <uniprot-id>P05091</uniprot-id>
        </enzyme>
      </enzymes>
    </reaction>
    <reaction>
      <sequence>3</sequence>
      <left-element>
        <drugbank-id>DBMET02092</drugbank-id>
        <name>3-(4-carboxybenzylidene)camphor</name>
      </left-element>
      <right-element>
        <drugbank-id>DBMET02093</drugbank-id>
        <name>3-(4-carboxybenzylidene)-6-hydroxycamphor</name>
      </right-element>
      <enzymes/>
    </reaction>
  </reactions>
  <snp-effects/>
  <snp-adverse-drug-reactions/>
  <targets>
    <target position="1">
      <id>BE0000557</id>
      <name>Progesterone receptor</name>
      <organism>Humans</organism>
      <actions>
        <action>antagonist</action>
      </actions>
      <references>
        <articles>
          <article>
            <ref-id>A19926</ref-id>
            <pubmed-id>15537743</pubmed-id>
            <citation>Schreurs RH, Sonneveld E, Jansen JH, Seinen W, van der Burg B: Interaction of polycyclic musks and UV filters with the estrogen receptor (ER), androgen receptor (AR), and progesterone receptor (PR) in reporter gene bioassays. Toxicol Sci. 2005 Feb;83(2):264-72. Epub 2004 Nov 10.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
        <attachments/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P06401" source="Swiss-Prot">
        <name>Progesterone receptor</name>
        <general-function>Zinc ion binding</general-function>
        <specific-function>The steroid hormones and their receptors are involved in the regulation of eukaryotic gene expression and affect cellular proliferation and differentiation in target tissues. Progesterone receptor isoform B (PRB) is involved activation of c-SRC/MAPK signaling on hormone stimulation.Isoform A: inactive in stimulating c-Src/MAPK signaling on hormone stimulation.Isoform 4: Increases mitochondrial membrane potential and cellular respiration upon stimulation by progesterone.</specific-function>
        <gene-name>PGR</gene-name>
        <locus>11q22-q23</locus>
        <cellular-location>Nucleus</cellular-location>
        <transmembrane-regions/>
        <signal-regions/>
        <theoretical-pi>6.45</theoretical-pi>
        <molecular-weight>98979.96</molecular-weight>
        <chromosome-location>11</chromosome-location>
        <organism ncbi-taxonomy-id="9606">Humans</organism>
        <external-identifiers>
          <external-identifier>
            <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
            <identifier>HGNC:8910</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenAtlas</resource>
            <identifier>PGR</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Gene Database</resource>
            <identifier>X51730</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Protein Database</resource>
            <identifier>35652</identifier>
          </external-identifier>
          <external-identifier>
            <resource>IUPHAR</resource>
            <identifier>627</identifier>
          </external-identifier>
          <external-identifier>
            <resource>Guide to Pharmacology</resource>
            <identifier>627</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProtKB</resource>
            <identifier>P06401</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProt Accession</resource>
            <identifier>PRGR_HUMAN</identifier>
          </external-identifier>
        </external-identifiers>
        <synonyms>
          <synonym>NR3C3</synonym>
          <synonym>Nuclear receptor subfamily 3 group C member 3</synonym>
          <synonym>PR</synonym>
        </synonyms>
        <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0001112|Progesterone receptor
MTELKAKGPRAPHVAGGPPSPEVGSPLLCRPAAGPFPGSQTSDTLPEVSAIPISLDGLLF
PRPCQGQDPSDEKTQDQQSLSDVEGAYSRAEATRGAGGSSSSPPEKDSGLLDSVLDTLLA
PSGPGQSQPSPPACEVTSSWCLFGPELPEDPPAAPATQRVLSPLMSRSGCKVGDSSGTAA
AHKVLPRGLSPARQLLLPASESPHWSGAPVKPSPQAAAVEVEEEDGSESEESAGPLLKGK
PRALGGAAAGGGAAAVPPGAAAGGVALVPKEDSRFSAPRVALVEQDAPMAPGRSPLATTV
MDFIHVPILPLNHALLAARTRQLLEDESYDGGAGAASAFAPPRSSPCASSTPVAVGDFPD
CAYPPDAEPKDDAYPLYSDFQPPALKIKEEEEGAEASARSPRSYLVAGANPAAFPDFPLG
PPPPLPPRATPSRPGEAAVTAAPASASVSSASSSGSTLECILYKAEGAPPQQGPFAPPPC
KAPGASGCLLPRDGLPSTSASAAAAGAAPALYPALGLNGLPQLGYQAAVLKEGLPQVYPP
YLNYLRPDSEASQSPQYSFESLPQKICLICGDEASGCHYGVLTCGSCKVFFKRAMEGQHN
YLCAGRNDCIVDKIRRKNCPACRLRKCCQAGMVLGGRKFKKFNKVRVVRALDAVALPQPV
GVPNESQALSQRFTFSPGQDIQLIPPLINLLMSIEPDVIYAGHDNTKPDTSSSLLTSLNQ
LGERQLLSVVKWSKSLPGFRNLHIDDQITLIQYSWMSLMVFGLGWRSYKHVSGQMLYFAP
DLILNEQRMKESSFYSLCLTMWQIPQEFVKLQVSQEEFLCMKVLLLLNTIPLEGLRSQTQ
FEEMRSSYIRELIKAIGLRQKGVVSSSQRFYQLTKLLDNLHDLVKQLHLYCLNTFIQSRA
LSVEFPEMMSEVIAAQLPKILAGMVKPLLFHKK</amino-acid-sequence>
        <gene-sequence format="FASTA">&gt;lcl|BSEQ0010387|Progesterone receptor (PGR)
ATGACTGAGCTGAAGGCAAAGGGTCCCCGGGCTCCCCACGTGGCGGGCGGCCCGCCCTCC
CCCGAGGTCGGATCCCCACTGCTGTGTCGCCCAGCCGCAGGTCCGTTCCCGGGGAGCCAG
ACCTCGGACACCTTGCCTGAAGTTTCGGCCATACCTATCTCCCTGGACGGGCTACTCTTC
CCTCGGCCCTGCCAGGGACAGGACCCCTCCGACGAAAAGACGCAGGACCAGCAGTCGCTG
TCGGACGTGGAGGGCGCATATTCCAGAGCTGAAGCTACAAGGGGTGCTGGAGGCAGCAGT
TCTAGTCCCCCAGAAAAGGACAGCGGACTGCTGGACAGTGTCTTGGACACTCTGTTGGCG
CCCTCAGGTCCCGGGCAGAGCCAACCCAGCCCTCCCGCCTGCGAGGTCACCAGCTCTTGG
TGCCTGTTTGGCCCCGAACTTCCCGAAGATCCACCGGCTGCCCCCGCCACCCAGCGGGTG
TTGTCCCCGCTCATGAGCCGGTCCGGGTGCAAGGTTGGAGACAGCTCCGGGACGGCAGCT
GCCCATAAAGTGCTGCCCCGGGGCCTGTCACCAGCCCGGCAGCTGCTGCTCCCGGCCTCT
GAGAGCCCTCACTGGTCCGGGGCCCCAGTGAAGCCGTCTCCGCAGGCCGCTGCGGTGGAG
GTTGAGGAGGAGGATGGCTCTGAGTCCGAGGAGTCTGCGGGTCCGCTTCTGAAGGGCAAA
CCTCGGGCTCTGGGTGGCGCGGCGGCTGGAGGAGGAGCCGCGGCTGTCCCGCCGGGGGCG
GCAGCAGGAGGCGTCGCCCTGGTCCCCAAGGAAGATTCCCGCTTCTCAGCGCCCAGGGTC
GCCCTGGTGGAGCAGGACGCGCCGATGGCGCCCGGGCGCTCCCCGCTGGCCACCACGGTG
ATGGATTTCATCCACGTGCCTATCCTGCCTCTCAATCACGCCTTATTGGCAGCCCGCACT
CGGCAGCTGCTGGAAGACGAAAGTTACGACGGCGGGGCCGGGGCTGCCAGCGCCTTTGCC
CCGCCGCGGAGTTCACCCTGTGCCTCGTCCACCCCGGTCGCTGTAGGCGACTTCCCCGAC
TGCGCGTACCCGCCCGACGCCGAGCCCAAGGACGACGCGTACCCTCTCTATAGCGACTTC
CAGCCGCCCGCTCTAAAGATAAAGGAGGAGGAGGAAGGCGCGGAGGCCTCCGCGCGCTCC
CCGCGTTCCTACCTTGTGGCCGGTGCCAACCCCGCAGCCTTCCCGGATTTCCCGTTGGGG
CCACCGCCCCCGCTGCCGCCGCGAGCGACCCCATCCAGACCCGGGGAAGCGGCGGTGACG
GCCGCACCCGCCAGTGCCTCAGTCTCGTCTGCGTCCTCCTCGGGGTCGACCCTGGAGTGC
ATCCTGTACAAAGCGGAGGGCGCGCCGCCCCAGCAGGGCCCGTTCGCGCCGCCGCCCTGC
AAGGCGCCGGGCGCGAGCGGCTGCCTGCTCCCGCGGGACGGCCTGCCCTCCACCTCCGCC
TCTGCCGCCGCCGCCGGGGCGGCCCCCGCGCTCTACCCTGCACTCGGCCTCAACGGGCTC
CCGCAGCTCGGCTACCAGGCCGCCGTGCTCAAGGAGGGCCTGCCGCAGGTCTACCCGCCC
TATCTCAACTACCTGAGGCCGGATTCAGAAGCCAGCCAGAGCCCACAATACAGCTTCGAG
TCATTACCTCAGAAGATTTGTTTAATCTGTGGGGATGAAGCATCAGGCTGTCATTATGGT
GTCCTTACCTGTGGGAGCTGTAAGGTCTTCTTTAAGAGGGCAATGGAAGGGCAGCACAAC
TACTTATGTGCTGGAAGAAATGACTGCATCGTTGATAAAATCCGCAGAAAAAACTGCCCA
GCATGTCGCCTTAGAAAGTGCTGTCAGGCTGGCATGGTCCTTGGAGGTCGAAAATTTAAA
AAGTTCAATAAAGTCAGAGTTGTGAGAGCACTGGATGCTGTTGCTCTCCCACAGCCAGTG
GGCGTTCCAAATGAAAGCCAAGCCCTAAGCCAGAGATTCACTTTTTCACCAGGTCAAGAC
ATACAGTTGATTCCACCACTGATCAACCTGTTAATGAGCATTGAACCAGATGTGATCTAT
GCAGGACATGACAACACAAAACCTGACACCTCCAGTTCTTTGCTGACAAGTCTTAATCAA
CTAGGCGAGAGGCAACTTCTTTCAGTAGTCAAGTGGTCTAAATCATTGCCAGGTTTTCGA
AACTTACATATTGATGACCAGATAACTCTCATTCAGTATTCTTGGATGAGCTTAATGGTG
TTTGGTCTAGGATGGAGATCCTACAAACACGTCAGTGGGCAGATGCTGTATTTTGCACCT
GATCTAATACTAAATGAACAGCGGATGAAAGAATCATCATTCTATTCATTATGCCTTACC
ATGTGGCAGATCCCACAGGAGTTTGTCAAGCTTCAAGTTAGCCAAGAAGAGTTCCTCTGT
ATGAAAGTATTGTTACTTCTTAATACAATTCCTTTGGAAGGGCTACGAAGTCAAACCCAG
TTTGAGGAGATGAGGTCAAGCTACATTAGAGAGCTCATCAAGGCAATTGGTTTGAGGCAA
AAAGGAGTTGTGTCGAGCTCACAGCGTTTCTATCAACTTACAAAACTTCTTGATAACTTG
CATGATCTTGTCAAACAACTTCATCTGTACTGCTTGAATACATTTATCCAGTCCCGGGCA
CTGAGTGTTGAATTTCCAGAAATGATGTCTGAAGTTATTGCTGCACAATTACCCAAGATA
TTGGCAGGGATGGTGAAACCCCTTCTCTTTCATAAAAAGTGA</gene-sequence>
        <pfams>
          <pfam>
            <identifier>PF00104</identifier>
            <name>Hormone_recep</name>
          </pfam>
          <pfam>
            <identifier>PF00105</identifier>
            <name>zf-C4</name>
          </pfam>
          <pfam>
            <identifier>PF02161</identifier>
            <name>Prog_receptor</name>
          </pfam>
        </pfams>
        <go-classifiers>
          <go-classifier>
            <category>component</category>
            <description>mitochondrial outer membrane</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>nucleoplasm</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>ATPase binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>DNA binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>enzyme binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>receptor binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>RNA polymerase II core promoter proximal region sequence-specific DNA binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>steroid binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>steroid hormone receptor activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>zinc ion binding</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>cell-cell signaling</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>epithelial cell maturation</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>gene expression</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>lung alveolus development</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>negative regulation of gene expression</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>ovulation from ovarian follicle</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>paracrine signaling</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>positive regulation of transcription from RNA polymerase II promoter</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>progesterone receptor signaling pathway</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>regulation of epithelial cell proliferation</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>signal transduction</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>tertiary branching involved in mammary gland duct morphogenesis</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>transcription initiation from RNA polymerase II promoter</description>
          </go-classifier>
        </go-classifiers>
      </polypeptide>
    </target>
    <target position="2">
      <id>BE0000132</id>
      <name>Androgen receptor</name>
      <organism>Humans</organism>
      <actions>
        <action>antagonist</action>
      </actions>
      <references>
        <articles>
          <article>
            <ref-id>A19926</ref-id>
            <pubmed-id>15537743</pubmed-id>
            <citation>Schreurs RH, Sonneveld E, Jansen JH, Seinen W, van der Burg B: Interaction of polycyclic musks and UV filters with the estrogen receptor (ER), androgen receptor (AR), and progesterone receptor (PR) in reporter gene bioassays. Toxicol Sci. 2005 Feb;83(2):264-72. Epub 2004 Nov 10.</citation>
          </article>
          <article>
            <ref-id>A19928</ref-id>
            <pubmed-id>24004914</pubmed-id>
            <citation>Jimenez-Diaz I, Molina-Molina JM, Zafra-Gomez A, Ballesteros O, Navalon A, Real M, Saenz JM, Fernandez MF, Olea N: Simultaneous determination of the UV-filters benzyl salicylate, phenyl salicylate, octyl salicylate, homosalate, 3-(4-methylbenzylidene) camphor and 3-benzylidene camphor in human placental tissue by LC-MS/MS. Assessment of their in vitro endocrine activity. J Chromatogr B Analyt Technol Biomed Life Sci. 2013 Oct 1;936:80-7. doi: 10.1016/j.jchromb.2013.08.006. Epub 2013 Aug 8.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
        <attachments/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P10275" source="Swiss-Prot">
        <name>Androgen receptor</name>
        <general-function>Zinc ion binding</general-function>
        <specific-function>Steroid hormone receptors are ligand-activated transcription factors that regulate eukaryotic gene expression and affect cellular proliferation and differentiation in target tissues. Transcription factor activity is modulated by bound coactivator and corepressor proteins. Transcription activation is down-regulated by NR0B2. Activated, but not phosphorylated, by HIPK3 and ZIPK/DAPK3.</specific-function>
        <gene-name>AR</gene-name>
        <locus>Xq11.2-q12</locus>
        <cellular-location>Nucleus</cellular-location>
        <transmembrane-regions/>
        <signal-regions/>
        <theoretical-pi>6.38</theoretical-pi>
        <molecular-weight>98987.9</molecular-weight>
        <chromosome-location>X</chromosome-location>
        <organism ncbi-taxonomy-id="9606">Humans</organism>
        <external-identifiers>
          <external-identifier>
            <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
            <identifier>HGNC:644</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenAtlas</resource>
            <identifier>AR</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Gene Database</resource>
            <identifier>M20132</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Protein Database</resource>
            <identifier>178628</identifier>
          </external-identifier>
          <external-identifier>
            <resource>IUPHAR</resource>
            <identifier>628</identifier>
          </external-identifier>
          <external-identifier>
            <resource>Guide to Pharmacology</resource>
            <identifier>628</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProtKB</resource>
            <identifier>P10275</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProt Accession</resource>
            <identifier>ANDR_HUMAN</identifier>
          </external-identifier>
        </external-identifiers>
        <synonyms>
          <synonym>DHTR</synonym>
          <synonym>Dihydrotestosterone receptor</synonym>
          <synonym>NR3C4</synonym>
          <synonym>Nuclear receptor subfamily 3 group C member 4</synonym>
        </synonyms>
        <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0000263|Androgen receptor
MEVQLGLGRVYPRPPSKTYRGAFQNLFQSVREVIQNPGPRHPEAASAAPPGASLLLLQQQ
QQQQQQQQQQQQQQQQQQETSPRQQQQQQGEDGSPQAHRRGPTGYLVLDEEQQPSQPQSA
LECHPERGCVPEPGAAVAASKGLPQQLPAPPDEDDSAAPSTLSLLGPTFPGLSSCSADLK
DILSEASTMQLLQQQQQEAVSEGSSSGRAREASGAPTSSKDNYLGGTSTISDNAKELCKA
VSVSMGLGVEALEHLSPGEQLRGDCMYAPLLGVPPAVRPTPCAPLAECKGSLLDDSAGKS
TEDTAEYSPFKGGYTKGLEGESLGCSGSAAAGSSGTLELPSTLSLYKSGALDEAAAYQSR
DYYNFPLALAGPPPPPPPPHPHARIKLENPLDYGSAWAAAAAQCRYGDLASLHGAGAAGP
GSGSPSAAASSSWHTLFTAEEGQLYGPCGGGGGGGGGGGGGGGGGGGGGGGGEAGAVAPY
GYTRPPQGLAGQESDFTAPDVWYPGGMVSRVPYPSPTCVKSEMGPWMDSYSGPYGDMRLE
TARDHVLPIDYYFPPQKTCLICGDEASGCHYGALTCGSCKVFFKRAAEGKQKYLCASRND
CTIDKFRRKNCPSCRLRKCYEAGMTLGARKLKKLGNLKLQEEGEASSTTSPTEETTQKLT
VSHIEGYECQPIFLNVLEAIEPGVVCAGHDNNQPDSFAALLSSLNELGERQLVHVVKWAK
ALPGFRNLHVDDQMAVIQYSWMGLMVFAMGWRSFTNVNSRMLYFAPDLVFNEYRMHKSRM
YSQCVRMRHLSQEFGWLQITPQEFLCMKALLLFSIIPVDGLKNQKFFDELRMNYIKELDR
IIACKRKNPTSCSRRFYQLTKLLDSVQPIARELHQFTFDLLIKSHMVSVDFPEMMAEIIS
VQVPKILSGKVKPIYFHTQ</amino-acid-sequence>
        <gene-sequence format="FASTA">&gt;lcl|BSEQ0020451|Androgen receptor (AR)
ATGGAAGTGCAGTTAGGGCTGGGAAGGGTCTACCCTCGGCCGCCGTCCAAGACCTACCGA
GGAGCTTTCCAGAATCTGTTCCAGAGCGTGCGCGAAGTGATCCAGAACCCGGGCCCCAGG
CACCCAGAGGCCGCGAGCGCAGCACCTCCCGGCGCCAGTTTGCTGCTGCTGCAGCAGCAG
CAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAGCAA
GAGACTAGCCCCAGGCAGCAGCAGCAGCAGCAGGGTGAGGATGGTTCTCCCCAAGCCCAT
CGTAGAGGCCCCACAGGCTACCTGGTCCTGGATGAGGAACAGCAACCTTCACAGCCGCAG
TCGGCCCTGGAGTGCCACCCCGAGAGAGGTTGCGTCCCAGAGCCTGGAGCCGCCGTGGCC
GCCAGCAAGGGGCTGCCGCAGCAGCTGCCAGCACCTCCGGACGAGGATGACTCAGCTGCC
CCATCCACGTTGTCCCTGCTGGGCCCCACTTTCCCCGGCTTAAGCAGCTGCTCCGCTGAC
CTTAAAGACATCCTGAGCGAGGCCAGCACCATGCAACTCCTTCAGCAACAGCAGCAGGAA
GCAGTATCCGAAGGCAGCAGCAGCGGGAGAGCGAGGGAGGCCTCGGGGGCTCCCACTTCC
TCCAAGGACAATTACTTAGGGGGCACTTCGACCATTTCTGACAACGCCAAGGAGTTGTGT
AAGGCAGTGTCGGTGTCCATGGGCCTGGGTGTGGAGGCGTTGGAGCATCTGAGTCCAGGG
GAACAGCTTCGGGGGGATTGCATGTACGCCCCACTTTTGGGAGTTCCACCCGCTGTGCGT
CCCACTCCTTGTGCCCCATTGGCCGAATGCAAAGGTTCTCTGCTAGACGACAGCGCAGGC
AAGAGCACTGAAGATACTGCTGAGTATTCCCCTTTCAAGGGAGGTTACACCAAAGGGCTA
GAAGGCGAGAGCCTAGGCTGCTCTGGCAGCGCTGCAGCAGGGAGCTCCGGGACACTTGAA
CTGCCGTCTACCCTGTCTCTCTACAAGTCCGGAGCACTGGACGAGGCAGCTGCGTACCAG
AGTCGCGACTACTACAACTTTCCACTGGCTCTGGCCGGACCGCCGCCCCCTCCGCCGCCT
CCCCATCCCCACGCTCGCATCAAGCTGGAGAACCCGCTGGACTACGGCAGCGCCTGGGCG
GCTGCGGCGGCGCAGTGCCGCTATGGGGACCTGGCGAGCCTGCATGGCGCGGGTGCAGCG
GGACCCGGTTCTGGGTCACCCTCAGCCGCCGCTTCCTCATCCTGGCACACTCTCTTCACA
GCCGAAGAAGGCCAGTTGTATGGACCGTGTGGTGGTGGTGGGGGTGGTGGCGGCGGCGGC
GGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGGCGAGGCGGGAGCTGTAGCCCCC
TACGGCTACACTCGGCCCCCTCAGGGGCTGGCGGGCCAGGAAAGCGACTTCACCGCACCT
GATGTGTGGTACCCTGGCGGCATGGTGAGCAGAGTGCCCTATCCCAGTCCCACTTGTGTC
AAAAGCGAAATGGGCCCCTGGATGGATAGCTACTCCGGACCTTACGGGGACATGCGTTTG
GAGACTGCCAGGGACCATGTTTTGCCCATTGACTATTACTTTCCACCCCAGAAGACCTGC
CTGATCTGTGGAGATGAAGCTTCTGGGTGTCACTATGGAGCTCTCACATGTGGAAGCTGC
AAGGTCTTCTTCAAAAGAGCCGCTGAAGGGAAACAGAAGTACCTGTGCGCCAGCAGAAAT
GATTGCACTATTGATAAATTCCGAAGGAAAAATTGTCCATCTTGTCGTCTTCGGAAATGT
TATGAAGCAGGGATGACTCTGGGAGCCCGGAAGCTGAAGAAACTTGGTAATCTGAAACTA
CAGGAGGAAGGAGAGGCTTCCAGCACCACCAGCCCCACTGAGGAGACAACCCAGAAGCTG
ACAGTGTCACACATTGAAGGCTATGAATGTCAGCCCATCTTTCTGAATGTCCTGGAAGCC
ATTGAGCCAGGTGTAGTGTGTGCTGGACACGACAACAACCAGCCCGACTCCTTTGCAGCC
TTGCTCTCTAGCCTCAATGAACTGGGAGAGAGACAGCTTGTACACGTGGTCAAGTGGGCC
AAGGCCTTGCCTGGCTTCCGCAACTTACACGTGGACGACCAGATGGCTGTCATTCAGTAC
TCCTGGATGGGGCTCATGGTGTTTGCCATGGGCTGGCGATCCTTCACCAATGTCAACTCC
AGGATGCTCTACTTCGCCCCTGATCTGGTTTTCAATGAGTACCGCATGCACAAGTCCCGG
ATGTACAGCCAGTGTGTCCGAATGAGGCACCTCTCTCAAGAGTTTGGATGGCTCCAAATC
ACCCCCCAGGAATTCCTGTGCATGAAAGCACTGCTACTCTTCAGCATTATTCCAGTGGAT
GGGCTGAAAAATCAAAAATTCTTTGATGAACTTCGAATGAACTACATCAAGGAACTCGAT
CGTATCATTGCATGCAAAAGAAAAAATCCCACATCCTGCTCAAGACGCTTCTACCAGCTC
ACCAAGCTCCTGGACTCCGTGCAGCCTATTGCGAGAGAGCTGCATCAGTTCACTTTTGAC
CTGCTAATCAAGTCACACATGGTGAGCGTGGACTTTCCGGAAATGATGGCAGAGATCATC
TCTGTGCAAGTGCCCAAGATCCTTTCTGGGAAAGTCAAGCCCATCTATTTCCACACCCAG
TGA</gene-sequence>
        <pfams>
          <pfam>
            <identifier>PF00104</identifier>
            <name>Hormone_recep</name>
          </pfam>
          <pfam>
            <identifier>PF00105</identifier>
            <name>zf-C4</name>
          </pfam>
          <pfam>
            <identifier>PF02166</identifier>
            <name>Androgen_recep</name>
          </pfam>
        </pfams>
        <go-classifiers>
          <go-classifier>
            <category>component</category>
            <description>cytoplasm</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>cytosol</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>nuclear chromatin</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>nucleoplasm</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>nucleus</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>protein complex</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>androgen binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>androgen receptor activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>ATPase binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>beta-catenin binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>chromatin binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>DNA binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>enzyme binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>protein dimerization activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>receptor binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>RNA polymerase II core promoter proximal region sequence-specific DNA binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>RNA polymerase II transcription factor binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>transcription factor activity, sequence-specific DNA binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>transcription factor binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>transcription regulatory region DNA binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>zinc ion binding</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>androgen receptor signaling pathway</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>cell growth</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>cell proliferation</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>cell-cell signaling</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>gene expression</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>intracellular receptor signaling pathway</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>negative regulation of cell proliferation</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>negative regulation of extrinsic apoptotic signaling pathway</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>negative regulation of integrin biosynthetic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>positive regulation of cell differentiation</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>positive regulation of cell proliferation</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>positive regulation of gene expression</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>positive regulation of integrin biosynthetic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>positive regulation of NF-kappaB transcription factor activity</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>positive regulation of phosphorylation</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>positive regulation of transcription from RNA polymerase II promoter</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>positive regulation of transcription from RNA polymerase III promoter</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>positive regulation of transcription, DNA-templated</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>prostate gland development</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>protein oligomerization</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>regulation of establishment of protein localization to plasma membrane</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>sex differentiation</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>signal transduction</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>small GTPase mediated signal transduction</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>transcription initiation from RNA polymerase II promoter</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>transcription, DNA-templated</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>transport</description>
          </go-classifier>
        </go-classifiers>
      </polypeptide>
    </target>
    <target position="3">
      <id>BE0000792</id>
      <name>Estrogen receptor beta</name>
      <organism>Humans</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <ref-id>A19966</ref-id>
            <pubmed-id>16079615</pubmed-id>
            <citation>Matsumoto H, Adachi S, Suzuki Y: [Estrogenic activity of ultraviolet absorbers and the related compounds]. Yakugaku Zasshi. 2005 Aug;125(8):643-52.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
        <attachments/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="Q92731" source="Swiss-Prot">
        <name>Estrogen receptor beta</name>
        <general-function>Zinc ion binding</general-function>
        <specific-function>Nuclear hormone receptor. Binds estrogens with an affinity similar to that of ESR1, and activates expression of reporter genes containing estrogen response elements (ERE) in an estrogen-dependent manner (PubMed:20074560). Isoform beta-cx lacks ligand binding ability and has no or only very low ere binding activity resulting in the loss of ligand-dependent transactivation ability. DNA-binding by ESR1 and ESR2 is rapidly lost at 37 degrees Celsius in the absence of ligand while in the presence of 17 beta-estradiol and 4-hydroxy-tamoxifen loss in DNA-binding at elevated temperature is more gradual.</specific-function>
        <gene-name>ESR2</gene-name>
        <locus>14q23.2</locus>
        <cellular-location>Nucleus</cellular-location>
        <transmembrane-regions/>
        <signal-regions/>
        <theoretical-pi>8.55</theoretical-pi>
        <molecular-weight>59215.765</molecular-weight>
        <chromosome-location>14</chromosome-location>
        <organism ncbi-taxonomy-id="9606">Humans</organism>
        <external-identifiers>
          <external-identifier>
            <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
            <identifier>HGNC:3468</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenAtlas</resource>
            <identifier>ESR2</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Gene Database</resource>
            <identifier>AB006590</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Protein Database</resource>
            <identifier>2911152</identifier>
          </external-identifier>
          <external-identifier>
            <resource>IUPHAR</resource>
            <identifier>621</identifier>
          </external-identifier>
          <external-identifier>
            <resource>Guide to Pharmacology</resource>
            <identifier>621</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProtKB</resource>
            <identifier>Q92731</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProt Accession</resource>
            <identifier>ESR2_HUMAN</identifier>
          </external-identifier>
        </external-identifiers>
        <synonyms>
          <synonym>ER-beta</synonym>
          <synonym>ESTRB</synonym>
          <synonym>NR3A2</synonym>
          <synonym>Nuclear receptor subfamily 3 group A member 2</synonym>
        </synonyms>
        <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0001580|Estrogen receptor beta
MDIKNSPSSLNSPSSYNCSQSILPLEHGSIYIPSSYVDSHHEYPAMTFYSPAVMNYSIPS
NVTNLEGGPGRQTTSPNVLWPTPGHLSPLVVHRQLSHLYAEPQKSPWCEARSLEHTLPVN
RETLKRKVSGNRCASPVTGPGSKRDAHFCAVCSDYASGYHYGVWSCEGCKAFFKRSIQGH
NDYICPATNQCTIDKNRRKSCQACRLRKCYEVGMVKCGSRRERCGYRLVRRQRSADEQLH
CAGKAKRSGGHAPRVRELLLDALSPEQLVLTLLEAEPPHVLISRPSAPFTEASMMMSLTK
LADKELVHMISWAKKIPGFVELSLFDQVRLLESCWMEVLMMGLMWRSIDHPGKLIFAPDL
VLDRDEGKCVEGILEIFDMLLATTSRFRELKLQHKEYLCVKAMILLNSSMYPLVTATQDA
DSSRKLAHLLNAVTDALVWVIAKSGISSQQQSMRLANLLMLLSHVRHASNKGMEHLLNMK
CKNVVPVYDLLLEMLNAHVLRGCKSSITGSECSPAEDSKSKEGSQNPQSQ</amino-acid-sequence>
        <gene-sequence format="FASTA">&gt;lcl|BSEQ0020485|Estrogen receptor beta (ESR2)
ATGGATATAAAAAACTCACCATCTAGCCTTAATTCTCCTTCCTCCTACAACTGCAGTCAA
TCCATCTTACCCCTGGAGCACGGCTCCATATACATACCTTCCTCCTATGTAGACAGCCAC
CATGAATATCCAGCCATGACATTCTATAGCCCTGCTGTGATGAATTACAGCATTCCCAGC
AATGTCACTAACTTGGAAGGTGGGCCTGGTCGGCAGACCACAAGCCCAAATGTGTTGTGG
CCAACACCTGGGCACCTTTCTCCTTTAGTGGTCCATCGCCAGTTATCACATCTGTATGCG
GAACCTCAAAAGAGTCCCTGGTGTGAAGCAAGATCGCTAGAACACACCTTACCTGTAAAC
AGAGAGACACTGAAAAGGAAGGTTAGTGGGAACCGTTGCGCCAGCCCTGTTACTGGTCCA
GGTTCAAAGAGGGATGCTCACTTCTGCGCTGTCTGCAGCGATTACGCATCGGGATATCAC
TATGGAGTCTGGTCGTGTGAAGGATGTAAGGCCTTTTTTAAAAGAAGCATTCAAGGACAT
AATGATTATATTTGTCCAGCTACAAATCAGTGTACAATCGATAAAAACCGGCGCAAGAGC
TGCCAGGCCTGCCGACTTCGGAAGTGTTACGAAGTGGGAATGGTGAAGTGTGGCTCCCGG
AGAGAGAGATGTGGGTACCGCCTTGTGCGGAGACAGAGAAGTGCCGACGAGCAGCTGCAC
TGTGCCGGCAAGGCCAAGAGAAGTGGCGGCCACGCGCCCCGAGTGCGGGAGCTGCTGCTG
GACGCCCTGAGCCCCGAGCAGCTAGTGCTCACCCTCCTGGAGGCTGAGCCGCCCCATGTG
CTGATCAGCCGCCCCAGTGCGCCCTTCACCGAGGCCTCCATGATGATGTCCCTGACCAAG
TTGGCCGACAAGGAGTTGGTACACATGATCAGCTGGGCCAAGAAGATTCCCGGCTTTGTG
GAGCTCAGCCTGTTCGACCAAGTGCGGCTCTTGGAGAGCTGTTGGATGGAGGTGTTAATG
ATGGGGCTGATGTGGCGCTCAATTGACCACCCCGGCAAGCTCATCTTTGCTCCAGATCTT
GTTCTGGACAGGGATGAGGGGAAATGCGTAGAAGGAATTCTGGAAATCTTTGACATGCTC
CTGGCAACTACTTCAAGGTTTCGAGAGTTAAAACTCCAACACAAAGAATATCTCTGTGTC
AAGGCCATGATCCTGCTCAATTCCAGTATGTACCCTCTGGTCACAGCGACCCAGGATGCT
GACAGCAGCCGGAAGCTGGCTCACTTGCTGAACGCCGTGACCGATGCTTTGGTTTGGGTG
ATTGCCAAGAGCGGCATCTCCTCCCAGCAGCAATCCATGCGCCTGGCTAACCTCCTGATG
CTCCTGTCCCACGTCAGGCATGCGAGGGCAGAAAAGGCCTCTCAAACACTCACCTCATTT
GGAATGAAGATGGAGACTCTTTTGCCTGAAGCAACGATGGAGCAGTGA</gene-sequence>
        <pfams>
          <pfam>
            <identifier>PF00104</identifier>
            <name>Hormone_recep</name>
          </pfam>
          <pfam>
            <identifier>PF00105</identifier>
            <name>zf-C4</name>
          </pfam>
          <pfam>
            <identifier>PF12497</identifier>
            <name>ERbeta_N</name>
          </pfam>
        </pfams>
        <go-classifiers>
          <go-classifier>
            <category>component</category>
            <description>extracellular region</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>mitochondrion</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>nucleoplasm</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>nucleus</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>core promoter sequence-specific DNA binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>DNA binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>enzyme binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>estrogen receptor activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>estrogen response element binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>receptor antagonist activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>RNA polymerase II transcription factor activity, ligand-activated sequence-specific DNA binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>steroid binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>steroid hormone receptor activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>transcription coactivator activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>transcription factor activity, sequence-specific DNA binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>zinc ion binding</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>cell-cell signaling</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>extracellular negative regulation of signal transduction</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>gene expression</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>intracellular estrogen receptor signaling pathway</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>negative regulation of cell growth</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>negative regulation of transcription from RNA polymerase II promoter</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>positive regulation of sequence-specific DNA binding transcription factor activity</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>positive regulation of transcription, DNA-templated</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>regulation of transcription, DNA-templated</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>signal transduction</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>transcription initiation from RNA polymerase II promoter</description>
          </go-classifier>
        </go-classifiers>
      </polypeptide>
    </target>
    <target position="4">
      <id>BE0000123</id>
      <name>Estrogen receptor alpha</name>
      <organism>Humans</organism>
      <actions/>
      <references>
        <articles>
          <article>
            <ref-id>A19966</ref-id>
            <pubmed-id>16079615</pubmed-id>
            <citation>Matsumoto H, Adachi S, Suzuki Y: [Estrogenic activity of ultraviolet absorbers and the related compounds]. Yakugaku Zasshi. 2005 Aug;125(8):643-52.</citation>
          </article>
          <article>
            <ref-id>A19928</ref-id>
            <pubmed-id>24004914</pubmed-id>
            <citation>Jimenez-Diaz I, Molina-Molina JM, Zafra-Gomez A, Ballesteros O, Navalon A, Real M, Saenz JM, Fernandez MF, Olea N: Simultaneous determination of the UV-filters benzyl salicylate, phenyl salicylate, octyl salicylate, homosalate, 3-(4-methylbenzylidene) camphor and 3-benzylidene camphor in human placental tissue by LC-MS/MS. Assessment of their in vitro endocrine activity. J Chromatogr B Analyt Technol Biomed Life Sci. 2013 Oct 1;936:80-7. doi: 10.1016/j.jchromb.2013.08.006. Epub 2013 Aug 8.</citation>
          </article>
        </articles>
        <textbooks/>
        <links/>
        <attachments/>
      </references>
      <known-action>unknown</known-action>
      <polypeptide id="P03372" source="Swiss-Prot">
        <name>Estrogen receptor</name>
        <general-function>Zinc ion binding</general-function>
        <specific-function>Nuclear hormone receptor. The steroid hormones and their receptors are involved in the regulation of eukaryotic gene expression and affect cellular proliferation and differentiation in target tissues. Ligand-dependent nuclear transactivation involves either direct homodimer binding to a palindromic estrogen response element (ERE) sequence or association with other DNA-binding transcription factors, such as AP-1/c-Jun, c-Fos, ATF-2, Sp1 and Sp3, to mediate ERE-independent signaling. Ligand binding induces a conformational change allowing subsequent or combinatorial association with multiprotein coactivator complexes through LXXLL motifs of their respective components. Mutual transrepression occurs between the estrogen receptor (ER) and NF-kappa-B in a cell-type specific manner. Decreases NF-kappa-B DNA-binding activity and inhibits NF-kappa-B-mediated transcription from the IL6 promoter and displace RELA/p65 and associated coregulators from the promoter. Recruited to the NF-kappa-B response element of the CCL2 and IL8 promoters and can displace CREBBP. Present with NF-kappa-B components RELA/p65 and NFKB1/p50 on ERE sequences. Can also act synergistically with NF-kappa-B to activate transcription involving respective recruitment adjacent response elements; the function involves CREBBP. Can activate the transcriptional activity of TFF1. Also mediates membrane-initiated estrogen signaling involving various kinase cascades. Isoform 3 is involved in activation of NOS3 and endothelial nitric oxide production. Isoforms lacking one or several functional domains are thought to modulate transcriptional activity by competitive ligand or DNA binding and/or heterodimerization with the full length receptor. Essential for MTA1-mediated transcriptional regulation of BRCA1 and BCAS3. Isoform 3 can bind to ERE and inhibit isoform 1.</specific-function>
        <gene-name>ESR1</gene-name>
        <locus>6q25.1</locus>
        <cellular-location>Nucleus</cellular-location>
        <transmembrane-regions/>
        <signal-regions/>
        <theoretical-pi>8.14</theoretical-pi>
        <molecular-weight>66215.45</molecular-weight>
        <chromosome-location>6</chromosome-location>
        <organism ncbi-taxonomy-id="9606">Humans</organism>
        <external-identifiers>
          <external-identifier>
            <resource>HUGO Gene Nomenclature Committee (HGNC)</resource>
            <identifier>HGNC:3467</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenAtlas</resource>
            <identifier>ESR1</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Gene Database</resource>
            <identifier>X03635</identifier>
          </external-identifier>
          <external-identifier>
            <resource>GenBank Protein Database</resource>
            <identifier>31234</identifier>
          </external-identifier>
          <external-identifier>
            <resource>IUPHAR</resource>
            <identifier>620</identifier>
          </external-identifier>
          <external-identifier>
            <resource>Guide to Pharmacology</resource>
            <identifier>620</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProtKB</resource>
            <identifier>P03372</identifier>
          </external-identifier>
          <external-identifier>
            <resource>UniProt Accession</resource>
            <identifier>ESR1_HUMAN</identifier>
          </external-identifier>
        </external-identifiers>
        <synonyms>
          <synonym>ER</synonym>
          <synonym>ER-alpha</synonym>
          <synonym>ESR</synonym>
          <synonym>Estradiol receptor</synonym>
          <synonym>NR3A1</synonym>
          <synonym>Nuclear receptor subfamily 3 group A member 1</synonym>
        </synonyms>
        <amino-acid-sequence format="FASTA">&gt;lcl|BSEQ0000246|Estrogen receptor
MTMTLHTKASGMALLHQIQGNELEPLNRPQLKIPLERPLGEVYLDSSKPAVYNYPEGAAY
EFNAAAAANAQVYGQTGLPYGPGSEAAAFGSNGLGGFPPLNSVSPSPLMLLHPPPQLSPF
LQPHGQQVPYYLENEPSGYTVREAGPPAFYRPNSDNRRQGGRERLASTNDKGSMAMESAK
ETRYCAVCNDYASGYHYGVWSCEGCKAFFKRSIQGHNDYMCPATNQCTIDKNRRKSCQAC
RLRKCYEVGMMKGGIRKDRRGGRMLKHKRQRDDGEGRGEVGSAGDMRAANLWPSPLMIKR
SKKNSLALSLTADQMVSALLDAEPPILYSEYDPTRPFSEASMMGLLTNLADRELVHMINW
AKRVPGFVDLTLHDQVHLLECAWLEILMIGLVWRSMEHPGKLLFAPNLLLDRNQGKCVEG
MVEIFDMLLATSSRFRMMNLQGEEFVCLKSIILLNSGVYTFLSSTLKSLEEKDHIHRVLD
KITDTLIHLMAKAGLTLQQQHQRLAQLLLILSHIRHMSNKGMEHLYSMKCKNVVPLYDLL
LEMLDAHRLHAPTSRGGASVEETDQSHLATAGSTSSHSLQKYYITGEAEGFPATV</amino-acid-sequence>
        <gene-sequence format="FASTA">&gt;lcl|BSEQ0021831|Estrogen receptor (ESR1)
ATGACCATGACCCTCCACACCAAAGCATCTGGGATGGCCCTACTGCATCAGATCCAAGGG
AACGAGCTGGAGCCCCTGAACCGTCCGCAGCTCAAGATCCCCCTGGAGCGGCCCCTGGGC
GAGGTGTACCTGGACAGCAGCAAGCCCGCCGTGTACAACTACCCCGAGGGCGCCGCCTAC
GAGTTCAACGCCGCGGCCGCCGCCAACGCGCAGGTCTACGGTCAGACCGGCCTCCCCTAC
GGCCCCGGGTCTGAGGCTGCGGCGTTCGGCTCCAACGGCCTGGGGGGTTTCCCCCCACTC
AACAGCGTGTCTCCGAGCCCGCTGATGCTACTGCACCCGCCGCCGCAGCTGTCGCCTTTC
CTGCAGCCCCACGGCCAGCAGGTGCCCTACTACCTGGAGAACGAGCCCAGCGGCTACACG
GTGCGCGAGGCCGGCCCGCCGGCATTCTACAGGCCAAATTCAGATAATCGACGCCAGGGT
GGCAGAGAAAGATTGGCCAGTACCAATGACAAGGGAAGTATGGCTATGGAATCTGCCAAG
GAGACTCGCTACTGTGCAGTGTGCAATGACTATGCTTCAGGCTACCATTATGGAGTCTGG
TCCTGTGAGGGCTGCAAGGCCTTCTTCAAGAGAAGTATTCAAGGACATAACGACTATATG
TGTCCAGCCACCAACCAGTGCACCATTGATAAAAACAGGAGGAAGAGCTGCCAGGCCTGC
CGGCTCCGCAAATGCTACGAAGTGGGAATGATGAAAGGTGGGATACGAAAAGACCGAAGA
GGAGGGAGAATGTTGAAACACAAGCGCCAGAGAGATGATGGGGAGGGCAGGGGTGAAGTG
GGGTCTGCTGGAGACATGAGAGCTGCCAACCTTTGGCCAAGCCCGCTCATGATCAAACGC
TCTAAGAAGAACAGCCTGGCCTTGTCCCTGACGGCCGACCAGATGGTCAGTGCCTTGTTG
GATGCTGAGCCCCCCATACTCTATTCCGAGTATGATCCTACCAGACCCTTCAGTGAAGCT
TCGATGATGGGCTTACTGACCAACCTGGCAGACAGGGAGCTGGTTCACATGATCAACTGG
GCGAAGAGGGTGCCAGGCTTTGTGGATTTGACCCTCCATGATCAGGTCCACCTTCTAGAA
TGTGCCTGGCTAGAGATCCTGATGATTGGTCTCGTCTGGCGCTCCATGGAGCACCCAGGG
AAGCTACTGTTTGCTCCTAACTTGCTCTTGGACAGGAACCAGGGAAAATGTGTAGAGGGC
ATGGTGGAGATCTTCGACATGCTGCTGGCTACATCATCTCGGTTCCGCATGATGAATCTG
CAGGGAGAGGAGTTTGTGTGCCTCAAATCTATTATTTTGCTTAATTCTGGAGTGTACACA
TTTCTGTCCAGCACCCTGAAGTCTCTGGAAGAGAAGGACCATATCCACCGAGTCCTGGAC
AAGATCACAGACACTTTGATCCACCTGATGGCCAAGGCAGGCCTGACCCTGCAGCAGCAG
CACCAGCGGCTGGCCCAGCTCCTCCTCATCCTCTCCCACATCAGGCACATGAGTAACAAA
GGCATGGAGCATCTGTACAGCATGAAGTGCAAGAACGTGGTGCCCCTCTATGACCTGCTG
CTGGAGATGCTGGACGCCCACCGCCTACATGCGCCCACTAGCCGTGGAGGGGCATCCGTG
GAGGAGACGGACCAAAGCCACTTGGCCACTGCGGGCTCTACTTCATCGCATTCCTTGCAA
AAGTATTACATCACGGGGGAGGCAGAGGGTTTCCCTGCCACGGTCTGA</gene-sequence>
        <pfams>
          <pfam>
            <identifier>PF00104</identifier>
            <name>Hormone_recep</name>
          </pfam>
          <pfam>
            <identifier>PF00105</identifier>
            <name>zf-C4</name>
          </pfam>
          <pfam>
            <identifier>PF02159</identifier>
            <name>Oest_recep</name>
          </pfam>
          <pfam>
            <identifier>PF12743</identifier>
            <name>ESR1_C</name>
          </pfam>
        </pfams>
        <go-classifiers>
          <go-classifier>
            <category>component</category>
            <description>cytoplasm</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>cytosol</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>Golgi apparatus</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>integral component of membrane</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>membrane</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>nuclear chromatin</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>nucleoplasm</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>nucleus</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>plasma membrane</description>
          </go-classifier>
          <go-classifier>
            <category>component</category>
            <description>transcriptionally active chromatin</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>ATPase binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>beta-catenin binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>chromatin binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>core promoter sequence-specific DNA binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>enzyme binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>estrogen receptor activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>estrogen response element binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>identical protein binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>nitric-oxide synthase regulator activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>RNA polymerase II core promoter proximal region sequence-specific DNA binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>RNA polymerase II transcription factor activity, estrogen-activated sequence-specific DNA binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>steroid binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>steroid hormone receptor activity</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>transcription factor activity, sequence-specific DNA binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>transcription factor binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>transcriptional activator activity, RNA polymerase II core promoter proximal region sequence-specific binding</description>
          </go-classifier>
          <go-classifier>
            <category>function</category>
            <description>zinc ion binding</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>androgen metabolic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>antral ovarian follicle growth</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>cellular response to estradiol stimulus</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>chromatin remodeling</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>epithelial cell development</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>epithelial cell proliferation involved in mammary gland duct elongation</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>gene expression</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>intracellular estrogen receptor signaling pathway</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>intracellular steroid hormone receptor signaling pathway</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>male gonad development</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>mammary gland alveolus development</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>mammary gland branching involved in pregnancy</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>negative regulation of gene expression</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>negative regulation of I-kappaB kinase/NF-kappaB signaling</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>negative regulation of sequence-specific DNA binding transcription factor activity</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>phospholipase C-activating G-protein coupled receptor signaling pathway</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>positive regulation of cytosolic calcium ion concentration</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>positive regulation of fibroblast proliferation</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>positive regulation of nitric oxide biosynthetic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>positive regulation of nitric-oxide synthase activity</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>positive regulation of phospholipase C activity</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>positive regulation of sequence-specific DNA binding transcription factor activity</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>positive regulation of transcription from RNA polymerase II promoter</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>positive regulation of transcription, DNA-templated</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>prostate epithelial cord arborization involved in prostate glandular acinus morphogenesis</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>prostate epithelial cord elongation</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>regulation of apoptotic process</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>regulation of branching involved in prostate gland morphogenesis</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>regulation of transcription, DNA-templated</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>response to estradiol</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>response to estrogen</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>signal transduction</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>transcription from RNA polymerase II promoter</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>transcription initiation from RNA polymerase II promoter</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>transcription, DNA-templated</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>uterus development</description>
          </go-classifier>
          <go-classifier>
            <category>process</category>
            <description>vagina development</description>
          </go-classifier>
        </go-classifiers>
      </polypeptide>
    </target>
  </targets>
  <enzymes/>
  <carriers/>
  <transporters/>
</drug>